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• 4E-BP: 4E-binding protein 
• Akt: protein kinase B 
• ANOVA: analysis of variance 
• C. elegans: Caenorhabditis elegans 
• CA: corpora allata 
• CC: corpora cardiac 
• CNS: central nervous system 
• D. melanogaster: Drosophila melanogaster 
• d2GAL/UAS-rpr: ablation of IPCs fly model 
• daGAL4/UAS-InRDN: ubiquitous expression of dominant negative insulin 
receptor fly model 
• DAPI: 4’,6-diamidino-2-phenylindole (a fluorescent dye) 
• EB: ellipsoid body 
• elavGAL4/+: elavGAL4 driver crossed with white Dahomey flies 
• elavGAL4/UAS-InRDN: neuronal specifically expression of dominant negative 
insulin receptor fly model 
• elavGAL4/UAS-PTEN: neuronal specifically expression of overexpression PTEN 
phosphatase fly model 
• elavGAL4: pan-neuronal driver that specifically expressed in all neurons 




• elavGS/UAS-PTEN: elavGS driver crossed with UAS-PTEN flies (without drug 
treatment) 
• FB: fan-shaped body 
• FOXO: forkhead transcription factor (dFOXO: Drosophila forkhead transcription 
factor) 
• GAL4/UAS system: GAL4/upstream activating sequence system 
• GH: growth hormone 
• GS: GeneSwitch system 
• hESC: human embryonic stem cells 
• HSC: hematopoietic stem cells 
• IGF: insulin/insulin-like growth factor 
• IIS pathway: Insulin/IGF-like signalling pathway 
• ILPs: insulin-like peptides (DILPs: Drosophila insulin-like peptides) 
• InR/IR: insulin/IGF-1 receptor (dInR: Drosophila insulin/IGF-1 receptor) 
• IPCs: insulin-producing cells 
• IRS: insulin receptor substrate 
• JNK pathway: Jun-NH2-terminal kinase pathway 
• LNds: dorso-lateral neurons 
• LNvs: PDF-positive ventrolateral neurons 
• MBONs: MB output neurons 
• MBs: mushroom bodies 
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• MNCs/mNSCs: median neurosecretory cells 
• Mth: Methuselah 
• NAD: nicotinamide adenine dinucleotide 
• NO: noduli 
• PB: protocerebral bridge 
• PBS: phosphate buffer saline 
• PDPK1: phosphoinositide dependent kinase 1 
• PFA: paraformaldehyde (fixation buffer) 
• PI3K: phosphatidylinositol 3-kinase 
• PIP2: phosphatidylinositol (4,5)-biophosphate 
• PIP3: phosphatidylinositol (3,4,5)-triphosphate 
• ROS: reactive oxygen species 
• RU486: mifepristone (an inducible drug for GS system) 
• RU486-elavGS/+: elavGS driver crossed with white Dahomey flies and treated 
with RU486 drug 
• RU486-elavGS/UAS-PTEN recovery: adult-specific neuronal expression of 
overexpression PTEN phosphatase fly model with a 5-day recovery period 
before each testing time point 
• RU486-elavGS/UAS-PTEN: adult-specific neuronal expression of 
overexpression PTEN phosphatase fly model 
• SEM: standard error of mean 
• SNP: single nucleotide polymorphisms 
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• SY: sugar and yeast 
• TGF- β: transforming growth factor-β 
• TOR pathway: target of rapamycin signalling pathway 
• TSH: thyroid-stimulating hormone 
• UAS-PTEN/+: UAS-PTEN driver crossed with white Dahomey flies 
• UAS-PTEN: PTEN overexpression UAS driver 
• Ub: ubiquitin molecule 
• UPS: ubiquitin-proteasome system 





With the steady increase of human lifespan in many countries, understanding the 
underlying mechanisms of aging has become a crucial research interest in order to 
promote human health and longevity and prevent age-associated diseases. Over the 
last few decades, many studies have shown that ageing is modulated by the 
evolutionarily conserved nutrient-sensing Insulin/IGF-like signalling (IIS) pathway. IIS 
interacts with multiple cellular processes, including cell growth, development, 
metabolic homeostasis, fecundity and stress resistance. Evidence has revealed a 
strong connection between systemically reduced IIS and extension of lifespan, ranging 
from invertebrate model organisms, Drosophila melanogaster, and Caenorhabditis 
elegans, to mammalians, mice and even humans. Systemic mediation of components 
in the IIS pathway has resulted in reduced fecundity, increased lifespan and 
accumulation of carbohydrates and lipids. However, there is still much to be 
discovered regarding the regulation of different IIS components in specific tissues or 
organs and their roles in ageing and longevity. Overexpression of dPTEN or dFOXO (the 
antagonistic regulators of the IIS pathway), systemically or tissue-specifically, is 
reported to extend lifespan or delay specific tissue or organ ageing such as muscle and 
cardiac ageing. However, little is known about the role of IIS in neuronal ageing. The 
effects of altered IIS on all neurons in Drosophila was recently tested using the insulin 
receptor dominant-negative model (elavGAL4/UAS-InRDN). This project aims to 
continue investigating the role of reduced IIS in neurons on brain functions, ageing, 
and longevity using inducible overexpression of PTEN to reduce IIS in the D. 
melanogaster model and to determine the role of reduced IIS during development and 
adulthood. The effects are tested through lifespan, behavioural senescence (negative 
geotaxis, exploratory walking, and sleeping behaviours), biochemistry and cellular 
experiments including stress resistance, glycogen, and lipid content assays, and 
apoptosis assay. Our results confirm that IIS modulated lifespan and healthspan 





2. Literature Review 
2.1 Introduction – Ageing Research 
Since the mid-nineteenth century, human life expectancy has significantly increased globally, 
mainly because of the largely improved public health measures, better sanitation, 
refrigeration, vaccination, and change of lifestyles (Partridge, 2010). With the still steadily 
increased human life expectancy, the majority of the global population has shifted to people 
at older age and population aged 60 or above is growing faster than all younger age groups. 
However, increased life expectancy is not always accompanied by a better healthy life 
expectancy and in fact, health expectancy is not increasing at the same rate as life expectancy. 
Infectious diseases are no longer the major causes of death while cardiovascular diseases, 
cancer, stroke, dementia, and so on have taken over the place and contribute to the mortality 
rate in an exponentially increasing rate (Wilmoth, 2000). Ageing is the major risk factor of 
those major causes of death. With more people living long enough to develop those diseases 
and experience age-related loss of functions, ageing has become a heated and challenging 
research area. 
With the development of ageing theories and the research into ageing mechanisms, ageing is 
now usually defined as a complex process of the accumulation of molecular, cellular, and 
organ damages, leading to significant substantial functional declines, reduced fertility, and 
increased chance of death (Fontana et al., 2010). Yet ageing shows significant differences 
across species: different species age at different rates and some species do not show age-
related changes in mortality and fertility (Kirkwood & Austad, 2000). The big variabilities across 
different tissues, individuals, and species are thought to be that ageing is caused by a complex 
combination of internal individual-specific mutations and different external factors 
(environmental exposure etc.) (Flatt and Schmidt, 2010). The complexity and variability of the 
ageing phenotype led to the conclusion that ageing is not an adaptive process but an 
unprogrammed side effect in evolution (Partridge & Gems, 2002). It is also concluded that 
ageing is a polygenic trait and no single gene is responsible specifically for the cause of ageing 
(Partridge & Gems, 2006).  
Since then, further research has changed directions and identified that evolutionarily 
conserved single genes and pathways can modulate ageing. In recent decades, it has been 




2.2 Lifespan Extension in Model Organisms 
The possibilities of lifespan modulation were first discovered during mutagenesis screening in 
Caenorhabditis elegans (worms) model back in the 1980s (Klass, 1983; Friedman & Johnson, 
1988). It revealed that a single gene mutation not only can extend the length of C. elegans's 
lifespan up to 2-fold but also accompany with improved health and senescence (Kenyon et al. 
1993). Piper et al. (2008) summarized interventions of several insulin signalling (IIS) ligands 
(INS-1, INS-7, and INS-18) and insulin receptors (DAF-2) to extend lifespan several times more 
than normal lifespan in C. elegans. Following those ground-breaking discovery of age-1, daf-2, 
and daf-16 involving in lifespan extension in C. elegans, other mutations with similar effects 
on lifespan in other model organisms were soon identified. Kaeberlein et al. (1999) identified 
that sir2 alone, a nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylase, 
can positively modulate lifespan in Saccharomyces cerevisiae (budding yeast). In Drosophila 
melanogaster model, Methuselah [(mth), a G-protein coupled receptors] was identified that 
can extend lifespan and modulate stress response (Lin et al. 1998); Clancy et al. (2001) 
identified the loss of Chico, an insulin receptor substrate protein, can extend lifespan. 
Researchers soon moved onto mammalian model organisms as well. In mice, multiple mutant 
models were discovered that live significantly longer than normal mice. For example, Ames 
dwarf mice, with a deficiency of anterior pituitary cells and thus a lack of the production of 
growth hormone (GH), prolactin, and thyroid-stimulating hormone (TSH) (Brown-Borg et al. 
1996). Although it remains controversial, another mouse model snell dwarf mice with a Pit1 
gene mutation was also found to have a longer lifespan and more resistant to stress, but 
subject to experimental conditions (Liang et al. 2003). In more recent studies, Taguchi et al. 
(2007) have reported mice with a heterozygous deletion of insulin receptor substrate 2 (IRS2) 
were long-lived and present symptoms of ameliorated ageing. Homozygous deletion of the 
insulin receptor, heterozygotes or homozygous deletion of IRS2, and heterozygous knockout 
of IGF1 (insulin/insulin-like growth factor 1) all result in long-lived mice model (Pan and Finkel, 
2017). Together with other studies, it has been firmly confirmed that the lifespan of different 
model organisms can be modulated by mutations in single genes. With those findings, there 
are some studies reported to test monkeys and also human volunteers with similar mutations. 
In a study of the biochemical and genetic variations of Ashkenazi Jewish centenarians, an 
overrepresentation of heterozygous mutations in the IGF1 was discovered among female 
centenarians (Suh et al. 2008). Genetic variants of forkhead (FOXO) transcription factors 
(FOXO1a and FOXO3a) show influences on human lifespan in the population-based Leiden 85-
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plus Study (Kuningas et al. 2007). The GH1 SNP (growth hormone 1 single nucleotide 
polymorphisms) is associated with growth hormone deficiency and decreased IIS signalling 
which is also reported to have a significant benefit in old age survival in human (Van Heemst 
et al., 2005).  
More importantly, age-1, daf-2, daf-16, Chico, IRS-2, FOXO, and so on are all important 
components of Insulin/insulin-like growth factor (IGF)-1 signalling (IIS) pathway in different 
model organisms (Fig. 2), leading to the investigation of the evolutionarily conserved role of 
the IIS pathway in longevity modulation. Evidence has confirmed that ageing is hormonally 
regulated by this evolutionarily conserved nutrient-sensing IIS pathway (Fontana et al., 2010) 
2.3 The Insulin Signalling Pathway  
The IIS pathway is a complex fundamental pathway that is involved in multiple cellular 
processes, such as the storage and synthesis of lipids, protein, carbohydrates, gene expression, 
cell growth, apoptosis, and so on (Fig. 1) (Riehle and Abel, 2016). It is initiated by the binding 
of insulin or insulin-like peptides to insulin receptor or insulin-like growth factor (IGF) tyrosine 
kinase receptor. The signal then triggers the activation of a network of intracellular signalling 
pathways such as PI3K/Akt (phosphatidylinositol 3-kinase/ the protein kinase B) directly or 
indirectly through insulin receptor substrates (IRS) proteins. PI3K catalyses the conversion of 
phosphatidylinositol (4,5)-biophosphate (PIP2) to phosphatidylinositol (3,4,5)-triphosphate 
(PIP3), leading to the cascade phosphorylation of phosphoinositide dependent kinase 1 
(PDPK1), kinase Akt, and other downstream factors. Akt is a central mediator in various cellular 
processes (Fig. 1) such as the transcriptional activity of Bcl2 (inhibits apoptosis), mTOR 
(promotes somatic growth and protein synthesis), eNOS (promotes vasodilation) (Riehle and 
Abel, 2014). Akt can also mediate the phosphorylation of members of the forkhead 
transcription factor (FOXO) family in the cytoplasm and inhibit its translocation into the 
nucleus. FOXO is the downstream factor in the IIS pathway that has been identified to 




Figure 1. The network of insulin/IGF-1 (IIS) signalling pathway  
A summary of the key elements involved in insulin/IGF-1 (IIS) signal transduction network and 
its role in different cellular processes. The pathway is initiated by the binding of the ligand 
(insulin or insulin-like peptides) to insulin receptor or IGF-1 receptor including receptor 
dimerization and autophosphorylation of the cytoplasmic domain. This results in the increase 
tyrosine kinase activities and the activation of IRS (IRS1/2) and PI3K. PI3K mediates the 
generation of PIP3 from PIP2 and leads to the phosphorylation of Akt and the cascade 




IIS pathway is evolutionarily conserved in different model organisms ranging from 
invertebrates to mammalians with different levels of complexity. Different model organisms 
consist of different number of the components in the IIS pathway: fly and worm model contain 
a single insulin-like receptor, multiple insulin-like peptide ligands (7 or 38 respectively), and 
mainly single isoforms of the other downstream factors; mammals (mice for example) have 
two isoforms of insulin receptor (IR-A and IR-B), an insulin-like receptor (IGF-1), one insulin 
and two IGF (IGF-1,2) ligands, and many isoforms of other components (Fig. 2) (Broughton and 
Partridge, 2009). 
Figure 2. The insulin/IGF-1 (IIS) signalling pathway in different model organisms (worms, flies, 
and mice) 
IIS pathway is conserved in different model organisms but is consisted of different numbers of 
the components. Signalling begins with the binding of ligands to the insulin receptor. The 
signal is then transferring either directly or indirectly through IRS to the downstream factor 
PI3K (or age-1 in worms) which promotes the conversion from PIP2 to PIP3. PTEN (or daf-18 in 
worms) function as the antagonist reverses PIP3 to PIP2. The signal then passes from PIP3 to 
PDK and PK (protein kinase) which phosphorylates forkhead transcription factor (FOXO or daf-
16 in worms) and leaves the nucleus. Different model organisms have different components 





IIS pathway also interacts with other pathways to regulate lifespan, such as the target of 
rapamycin (TOR) signalling pathway and the Jun-NH2-terminal kinase (JNK) pathway (Fig. 3) 
(Broughton and Partridge, 2009). TOR pathway is an evolutionarily conserved pathway that 
controls and regulates protein synthesis and growth in response to nutrient levels (amino acids 
and growth factors) and reduced TOR mimics effects similar to dietary restriction and extends 
lifespan (Mair and Dillin, 2008). The IIS/TOR network is not yet thoroughly investigated but 
reduced activity of this network can extend lifespan, improve some measures of health and 
function during ageing, and also reduce the potential risks of specific ageing-related diseases 
(Partridge et al. 2011). On the other hand, JNK pathway responds to environmental-induced 
stress changes (such as UV irradiation, oxidative stress, and DNA damage) and the 
transforming growth factor-β (TGF- β) signalling pathway and it is involved in FOXO-dependent 
lifespan extension (Wang et al. 2005). JNK pathway functions as a regulator of IIS pathway that 
it restricts IIS activity, induces FOXO nuclear localization, and thus promotes lifespan extension 
and stress resistance (Karpac et al., 2011).   
Figure 3. The IIS pathway interacts with other pathways 
(1) TOR pathway is an evolutionarily conserved nutrient-sensing pathway in response to 
nutrient uptake (amino acids and growth factors). TOR pathway interacts with IIS pathway at 
multiple points: the activation of the S6 kinase (S6K) by TOR inhibits the activation of PI3K; the 
activation of PKB by PI3K inhibits TSC1-TSC2 (tuberous sclerosis complex 1 and 2) and forms a 
positive feedback loop to activate TOR pathway. (2) JNK is another conserved pathway in 
response to environmental stress such as UV radiation, oxidative stress, DNA damage, heat, 
and inflammatory cytokines. JNK pathway antagonizes the IIS pathway and promotes FOXO 
nuclear localization. (Taken from Broughton and Partridge, 2009). 
17 
 
FOXO proteins play the most critical role in IIS pathway and they are a subgroup of the 
Forkhead family of transcription factors which is characterized by a conserved DNA-binding 
domain (the Forkhead box or FOX) (Mathew et al., 2017). In the absence of growth factor or 
under cellular stress, FOXO transcription factors translocate into the nucleus and promote 
gene expressions mainly by binding the consensus core recognition motif TTGTTTAC (Martins 
et al., 2016). By activating the expression of target genes, FOXOs promote different cellular 
processes: initiating apoptosis by activating FasL ligand of the Fas-dependent cell death 
pathway and activating Bim of the pro-apoptotic Bcl-2 family; regulating stress resistance by 
upregulating Catalase and MnSOD; promoting DNA repair by upregulating GADD45 and DDB1; 
facilitating cell cycle arrest by upregulating the cell-cycle inhibitor p27 and GADD45; regulating 
glucose metabolism by expressing gluconeogenic genes such as G6Pase and PEPCK; also 
involves in muscle atrophy, energy homeostasis, and so on (Fig. 4) (Carter and Brunet, 2007; 
Ma et al., 2018; Nakae et al., 2008). FOXO proteins are tightly regulated to ensure the precise 
transcription of specific target genes. Apart from phosphorylation by Akt in response to 
growth factors or JNK upon cellular stress, FOXOs are also regulated by various post-
translational modifications including acetylation or deacetylation, ubiquitination, and 





Figure 4. The cellular processes and gene expression programs regulated by FOXO 
In the absence of growth factor signalling or under cellular stress, FOXOs translocate into the 
nucleus and initiates the expression of target genes. FOXO target genes play a role in cell 
death, reactive oxygen species (ROS) detoxification, DNA repair, cell cycle arrest, glucose 





FOXOs have long been associated with longevity and homeostasis and a recent study has 
reported a dramatic decline in the number of FOXO-bound genes during ageing: dropping from 
2617 at young ages to 224 at old ages (Birnbaum et al., 2018). However, the mechanisms by 
which FOXOs modulate lifespan extension still remains unclear but several mechanisms have 
been suggested. One of the mechanisms proposed was through the maintenance of 
proteostasis as FOXOs are key regulators of autophagy and the ubiquitin-proteasome system 
(UPS) (Webb and Brunet, 2014). Autophagy occurs to degrade and recycle cytoplasmic 
proteins and organelles in response to starvation and environmental stress (Simonsen et al., 
2008). Reduced autophagy is one of the hallmarks of ageing and age-related disorders with 
the accumulation of cellular damaged cytoplasmic constituents (Toth et al., 2008). FOXOs can 
regulate the expression of autophagy genes in different cell types including muscle, neurons, 
cardiomyocytes, renal tubular cells, and hematopoietic stem cells (HSC) from flies (dFOXO) to 
mammals (FOXO1 and FOXO3) (Webb and Brunet, 2014). Reduced proteotoxicity is associated 
with the prevention of age-related damage accumulation and the promotion of longevity that 
the overexpression of dFOXO or 4E-BP (4E-binding protein) in muscle was sufficient to extend 
lifespan in flies and improve some extent of protein homeostasis in other tissues (Demontis 
and Perrimon, 2010). UPS is another clearance mechanism responsible for degrading including 
many regulated, short-lived, abnormal, and denatured proteins; through a three-step cascade 
mechanism, a ubiquitin molecule (Ub) is passed on from E1-activating enzyme, E2-conjugating 
enzyme, and E3 ubiquitin ligases to attach to the targeted protein for degradation (Lilienbaum, 
2013). FOXOs are regulators for the transcription of atrophy-related muscle-specific E3 genes, 
such as atrogin-1 and MuRF-1 (Sandri et al., 2004; Bodine and Baehr, 2014). In addition to 
upregulation of ubiquitin ligases, FOXOs regulate proteolysis by controlling the composition of 
the proteasome: FOXO4 is sufficient for the expression of the proteasome component 
PSMD11, the mediator of proteasome assembly and activities in human embryonic stem cells 
(hESC) (Vilchez et al., 2012). 
Two other proposed mechanisms of FOXO-modulated longevity are based on the role of 
FOXOs in cellular responses to oxidative stress and stem cell regenerations (Martins et al., 
2016). Oxidative stress is the dynamic equilibrium between the generation of ROS such as OH, 
O2-, H2O2, or O2, and antioxidant defence mechanisms (Sander et al. 2004). Oxidative stress is 
one of the key factors that limit lifespan as it contributes to lifetime-accumulated damages in 
ageing and age-related diseases. FOXOs may influence ageing by increasing the antioxidant 
capacity of cells that FOXOs are regulated by oxidative stress to upstream pathways (such as 
JNK) and FOXOs regulate the key detoxification enzymes (such as MnSOD, GADD45, and 
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catalase in Fig. 4) (Storz, 2011). On the other hand, longevity is also dependent on the 
maintenance of tissue homeostasis, the balance of removal, regeneration, and differentiation 
of adult stem cells in tissues (Boyette and Tuan, 2014). FOXOs maintain the renewal of HSC 
through different aspects: regulating cell cycle mediators (such as p130, p27, p57, p21, cyclin 
G2, and cyclin G2) to prevent aberrant entry into next cycle; inhibiting apoptosis (upregulating 
FasL and Bim) to maintain the stem cell pool; mediating resistance to oxidative stress to 
maintain potential self-renewal (Tothova and Gilliland, 2007). In addition to adult stem cells, 
FOXOs can maintain the pluripotency of hESC directly that FOXO1 directly control the 
expression of OCT4 and SOX2 (key factors in the feedback circuit regulating ESC pluripotency 
during development (Zhang et al., 2011).  
Due to the diverse functions of IIS in cell growth, development, metabolic homoeostasis, 
fecundity and stress resistance, manipulations of IIS can be a double-edged sword. Therefore, 
research is aiming to identify the optimal time and space of IIS reduction through the right 
manipulation of the component in the right tissue for lifespan extension and health and 
function improvement with the least negative peripheral effects (Broughton and Partridge, 
2009). 
2.4 The IIS in Drosophila Model 
For ageing research, it is difficult to study in human as human has a longer lifespan and ethical 
issues involved. Therefore, enormous research into the underlying mechanisms of ageing has 
been using a variety of model organisms to study the evolutionary conservation of genes and 
pathways. The aim is to study the functions and mechanisms of those genes and pathways in 
longevity in model organisms and to transfer to human in the future. Fruit fly (Drosophila 
melanogaster), nematode C. elegans, and mouse Mus musculus have been largely used as 
model organisms that each has its advantages and limitations. Drosophila is a good model to 
use in ageing research because of its short lifespan (usually 50-80 days in laboratory 
conditions), fast development to adulthood, cheap maintenance, fully sequenced genome, 
and well-established genetic tools for gene manipulation (Groteweil, et al. 2005). It is also 
closer to mammal comparing to C. elegans that flies have a well-differentiated brain, complex 




The IIS pathway of Drosophila melanogaster starts with the binding of insulin-like peptides 
(DILPs) to insulin/IGF-1 receptor (dInR), triggering a cascade of intracellular phosphorylation 
of downstream factors and phosphorylating the transcription factor (dFOXO) through the 
dPI3K/dAkt pathway (Fig. 5). dPTEN functions as antagonize enzymes that negatively regulate 
IIS by reversing the transformation of PIP2 to PIP3. In Drosophila, the IIS pathway contains 
mainly single isoforms of its components including the insulin-like receptor (dInR), the insulin 
receptor substrate Chico, the kinase PI3K (Dp110/p60 two subunits), the protein kinase 
dPDK1, the protein kinase dAkt1, and the transcription factor dFOXO (Broughton et al., 2010). 
The diverse functions of IIS in Drosophila may be the result of diversified IIS ligands (DILPs). 
The Drosophila genome encodes eight DILPs that each is expressed in a distinct expression 
pattern that is tissue-specific and dependent on developmental stage (Fig. 6) (Nässel and 
Broeck, 2015).  
Figure 5. Conserved insulin/IGF-1 signalling pathway in Drosophila melanogaster 
Signalling begins with the binding of insulin-like peptides, DILPs, to insulin/IGF-1 receptor, 
dInR. The activation of the insulin receptor directly or indirectly through Chico, activates PI3K, 
following by promoting the transformation of PIP2 into the second messenger PIP3. Elevated 
levels of PIP3 subsequently phosphorylates a series of downstream factors, from dPDK1, dAkt1 
to downstream transcription factor dFOXO. Phosphorylated dFOXO results in its inactivation 
and exclusion from the nucleus, thus, the inhibition of target longevity genes expression. 
Conversely, dPTEN functions as an antagonize enzymes to decrease the level of PIP3 and its 
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downstream factors, leading to the activation of dFOXO and the upregulation of longevity 
genes expression (Taken from Altintas et al., 2016). 
DILP2, DILP3, and DILP5 are the most studied peptides that they are produced by a set of 
median neurosecretory cells (MNCs/ mNSCs) [the insulin-producing cells (IPCs)] in the brain, 
which are then released into the open circulation from axon terminations in neurohemal areas 
of the corpora cardiac (CC) and corpora allata (CA), as well as on the surface of the anterior 
aorta and intestine (Liu et al., 2016). These DILPs are expressed throughout the lifespan from 
the embryo (mesoderm) to adults and they are produced in other cells as well. DILP2 is the 
closest homolog of human insulin and it is also expressed in imaginal discs and salivary glands 
in larva (Brogiolo et al., 2001). DILP3 is abundantly expressed in the muscle cells of the midgut 
in adults while DILP5 is expressed in principal cells of the renal tubules and follicle cells of the 
female ovary (Veenstra et al., 2008; Soderberg et al., 2011). A compensatory regulation also 
exists between these three DILPs that the knockdown of DILP2 leads to the upregulation of 
DILP3 and DILP5 while DILP3 is required for the expression of DILP2 and DILP5 (Broughton et 
al., 2008). DILP6 is an IGF-like peptide that it is mainly produced in the larval and adult fat body 
to regulate growth upon starvation; it is also expressed in larval salivary glands, surface glial 
cells in the ventral nerve cord (Slaidina et al., 2009; Chell and Brand, 2010). DILP7 is produced 
by about 20 neurons in the abdominal neuromeres of the ventral nerve cord of larvae and 
adults and it is important in the regulation of gut functions, tracheal growth, and fecundity 
(Miguel-Aliaga et al., 2008; Yang et al., 2008; Linneweber et al., 2014). DILP8 is found in the 
imaginal discs of larvae and plays a role in the regulation of developmental timing and growth 
(Colombani et al., 2012; Garelli et al., 2012). DILP8 is also released from the adult female ovary 
and may be important for reproductive function by signalling to Lgr3 (a G protein-coupled 
receptor for DILP8)-expressing neurons (Meissner et al., 2016). The expression of DILP1 and 
DILP4 is limited to development stages that DILP4 is only found in the embryonic midgut and 




Figure 6. The summary of the production and releasing of DILPs in Drosophila melanogaster 
DILP2, DILP3, and DILP5 are produced in the insulin-producing cells (IPCs) of the brain and 
released from axon terminations in the corpora cardiac (CC) and corpora allata (CA) as well as 
the surface of the anterior aorta and intestine. DILP3 is also found in the muscle cells of 
midgut while DILP5 in the ovaries and renal tubules. DILP6 is mainly expressed in the fat body 
as well as surface glial cells. DILP7 is produced by neurons in the abdominal ganglia then 
released up to the central nervous system (CNS), and down to the posterior intestine and 
oviduct. DILP8 is found in imaginal discs in the larva and ovaries of adults. DILP1 and DILP4 are 




Each factor in the IIS pathway plays a critical role and previous research has found that 
systemically reduced IIS by different points of the IIS is sufficient to extend Drosophila lifespan 
and improve some measures of health and function. Reduced IIS signalling by downregulation 
of dInR or loss of Chico significantly extends the lifespan of Drosophila by 36-85% (Tatar et al., 
2001; Tu et al., 2002). The knockdown of three DILPs (DILP2, 3, and 5) individually or in 
combination can alter the systemic insulin signalling, resulted in reduced fecundity, increased 
lifespan and accumulation of carbohydrates and lipids (Broughton et al., 2005; Nässel et al., 
2015). For the antagonistic regulators of the IIS pathway, like dPTEN or dFOXO, the 
upregulation or overexpression of them also increase the longevity and delay specific tissue 
or organ ageing such as muscle and cardiac ageing (Hwangbo et al., 2004; Wessells et al., 2004; 
Demontis and Perrimon, 2010). dFOXO also forms a feedback regulatory loop that regulates 
dInR receptor directly to mediate IIS signalling level (Puig et al., 2003). 
Tissue-specific modulation of IIS is also sufficient to increase longevity. Hwangbo et al. (2004) 
demonstrated that upregulating dFOXO in the adult pericerebral fat body was enough to 
regulate ageing, reduce the expression of DILP2, and repress endogenous IIS signalling in the 
peripheral fat body. Their findings also suggested that IIS modulates ageing through both 
autonomous and non-autonomous ways. 4E-BP is the target of dFOXO and plays a role in 
proteostasis by removing damaged protein aggregates through autophagy and the 
upregulation of dFOXO/4E-BP can preserve physical functions at least partially by promoting 
the autophagy/lysosome system (Rubinsztein, 2006). The increased activity of dFOXO/4E-BP 
in muscles only slowed muscle functional decline and was sufficient to extend Drosophila 
lifespan; dFOXO/4E-BP signalling can mimic the protective effects of decreased nutrient intake 
and regulate proteostasis, the release of insulin, and the expression of 4E-BP organism-wide 
(Demontis and Perrimon, 2010). Giannakou et al. (2004) confirmed tissue-specific modulation 
of IIS can increase lifespan by the overexpression of dFOXO in adult fat body but also suggested 
that IIS reduction in adults was sufficient to influence longevity and fecundity. The ablation of 
IPCs in adult fly brains also achieved lifespan extension with additional physiological outcomes 
such as increased resistance to starvation (increased level of glycogen and triglyceride), 
reduced female fecundity, and decreased mortality rates (Broughton et al, 2005; Haselton et 
al., 2010). More recent results have pointed out that the life-extension effects induced by 
FOXO overexpression in the gut/fat body or in neuroendocrine cells are independent from the 
presence of FOXO in the rest of the body (Alic et al., 2014). Whether or not tissue-specific 
modulation of IIS can extend lifespan depending on the tissue involved and through localized 
FOXO activation signalling to other downstream factors (Alic et al., 2014). 
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Tissue-specific modulation of IIS extending lifespan was also established in other models as 
well such as in the worm and the mouse (Bluher et al., 2003; Alic et al. 2004). It is also 
suggested that IIS reduction in adulthood only is sufficient to influence longevity and avoid any 
potential detrimental effects during development. This has led the research focusing on tissue-
specific and time-specific IIS modulation to promote longevity with minimal detrimental 
effects on the peripheral effects (Broughton and Partridge, 2009). 
2.5 IIS and the Central Nervous System (CNS) 
Little is known about the role of reduced IIS in the central nervous system (CNS) on ageing and 
functions. IIS plays diverse roles in the CNS and IIS reductions in the CNS can be controversial 
as lowered IIS can extend lifespan but may also comprise the integrity of the CNS (Broughton 
and Partridge, 2009).  
It has been established that IIS pathway can function cell non-autonomously in the regulation 
of ageing (mutations in one cell type can alter the phenotype of the whole organism); the fat-
specific IIS reductions in worms, mice, and flies are sufficient to increase lifespan (Russel and 
Kahn, 2007). The role of the CNS in IIS-induced lifespan extension is also predominately 
through endocrine signalling by secreting DILPs from the mNSCs and acting as a positive 
regulator of IIS (Broughton et al., 2005). DILP2, DILP3, and DILP5 are released from the mNSCs 
into the circulatory system, thus activating IIS in peripheral tissues and regulating IIS in the 
whole organism (Brogiolo et al., 2001). The ablation of mNSCs reduces one or more of DILPs 
to lower IIS systemically and extend fly lifespan, increase resistance to oxidative stress and 
starvation, and increase lipid and carbohydrate storage (Broughton et al., 2005). The selective 
alteration in some of the IPCs rather than all neurons achieved the same extent of lifespan 
extension, accomplished with the reduction of DILP2 mRNA levels and the level of IIS (PI3K 
activity) in the peripheral tissues (Fat body) (Bauer et al., 2007). As JNK pathway is involved in 
FOXO-dependent lifespan modulation, increases in the JNK pathway in neurons using the pan-
neuronal driver (elavGAL4, a specific driver expressed in all neurons) was sufficient enough to 
extend lifespan and increase the tolerance of oxidative stress in neurons (Wang et al., 2003). 
This JNK-induced lifespan extension further indicates a role of the IPCs via the downregulation 
of DILP production in response to oxidative stress and JNK activation (Wang et al., 2005).  
On the other hand, the cell-autonomous effects in the CNS may also play a role in IIS-mediated 
lifespan extension. IIS pathway has been found to play roles in CNS development and function, 
including axonal guidance, neurogenesis, neuronal survival, protection from apoptosis, and 
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cognition (Broughton and Partridge, 2009). Therefore, reducing IIS can affect its downstream 
target and whole-organism survival via the CNS and the neuronal survival and health.  
It is possible that IIS reductions induce lifespan extension but have negative or neutral effects 
to CNS function and behavioural senescence. In fact, currently, there is evidence shown both 
negative and positive effects on behavioural functions by IIS reductions. Reduced IIS lowered 
the learning capacity of nematodes while increased IIS Improved their learning performance 
(Vellai et al., 2006). Another IIS-induced long-lived worm model did not show improvement in 
their long-term memory at older ages but present improved memory and improved learning 
capacity at young ages (Tomioka et al., 2006). The deletion of IRS-2 in mice CNS specifically 
has shown a decrease in NMDA receptor-dependent synaptic plasticity in the hippocampus at 
young ages (Costello et al., 2012). In contrast, long-lived Ames dwarf mice with deficiencies in 
GH showed no age-related decline in locomotor behaviours and improved age-related 
memory retention (Kinney et al., 2001). Similarly, long-lived fly models either Chico mutant or 
the overexpression of FOXO in muscles have also shown an amelioration in their negative 
geotaxis (a locomotor behaviour), mainly as a result of the improvements in muscle function 
and the effects on walking speed with age (Martin and Grotewiel, 2006; Demontis and 
Perrimon, 2010). Recent data has demonstrated that neural-restricted IIS reduction was 
sufficient to increase female lifespan in flies but show neutral or detrimental effects on the 
behavioural decline, suggesting the disconnection between the role of IIS in lifespan extension 
and behavioural senescence (Ismail et al., 2015).  
2.6 UAS-GAL4 System and GeneSwitch System 
To study the role of IIS signalling in specific tissues or cells, a system is needed to manipulate 
the level of IIS spatially and temporally. The GAL4/upstream activating sequence (UAS) system 
is one of the most powerful genetic tools for targeted gene manipulation, developed by Brand 
and Perrimon (Brand and Perrimon, 1993). This system is based on the yeast GAL4 
transcription factor which can promote the transcription of the target genes by binding to UAS 
cis-regulatory sites (Busson and Pret, 2007). One DNA plasmid construct contains the gene-
specific promoter region for the gene of interest driving the expression of the GAL4 gene, 
controlling the expression of GAL4 in the specific tissue based on its specific promoter; the 
second DNA construct contains the GAL4 binding sites (UAS) driving the expression of any 
given transgene that is able to express the transgene when bound by GAL4 (Fig. 7) (Nichols, 
2006). Through standard embryo injection procedures, these two DNA construct can create 
two transgenic fly strains. Once these GAL4 and UAS strains mated with each other, the 
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offsprings contain both constructs, the expression of the transgene in the tissue of interest 
determined by the GAL4 promoter. 
Figure 7. The diagram of the UAS-GAL4 system 
This system is based on the yeast GAL4 transcription factor and its upstream activating 
sequence (UAS) which can remain silent until the binding of GAL4. One fly strain contains 
GAL4 factor driven by a gene-specific promoter that can only be expressed in specific tissue; 
another fly strain contains GAL4 binding sites (UAS) and a responder transgene (eg reporter 
gene or RNAi). By crossing the two strains, the progeny expresses the gene of interest 





To develop temporal control over UAS-transgene expression on top of its spatial control, a 
usage of conditional RU486-dependent GAL4 protein (GeneSwitch) in Drosophila was 
established (Osterwalder et al., 2001). This system is achieved by replacing GAL4 with the 
GeneSwitch protein that it is based on a chimeric GAL4 protein that contains the GAL4 DNA 
binding domain, the human progesterone receptor ligand-binding domain, and the activation 
domain from the human protein p65 (Roman et al., 2001). GeneSwitch transcriptional activity 
depends on the presence of its activator RU486 (mifepristone) that the expression of the 
target gene can be detected 5h after being treated with RU486 food and the transgene 
expression levels are dependent on the concentration of RU486 (Osterwalder et al., 2001). 
There are also other methods for temporal control over tissue-specific expressions in 
Drosophila, such as the tetracycline-dependent ‘tet-off’ or ‘tet-on’ transactivation systems or 
the GAL80 target system. However, both are limited and have adverse effects on the flies 
either by the requirement of continuous doxycycline or temperature, thus, unsuitable for 
ageing studies (Barwell et al., 2017). 
2.7 Preliminary Data 
To investigate the role of IIS in the ageing and function of the Drosophila Brain, previously 
Ismail et al. (2015) used three reduced IIS transgene models to study the changes in 
behavioural senescence (daGAL4/UAS-InRDN – ubiquitous expression of dominant negative 
insulin receptor; d2GAL/UAS-rpr – ablation of IPCs; elavGAL4/UAS-InRDN – neuronal specifical 
expression of dominant negative insulin receptor). Ageing research in model organisms has 
been largely using behavioural analysis to study the changes of functional healthspan in long-
lived models. In this paper, they have compared the effects of IIS reduction ubiquitously or 
neuron-specifically on lifespan and locomotor behaviours. Negative geotaxis is a reflex motor 
behaviour as a part of escape behaviours in flies that flies respond to sudden movements and 
tend to climb higher. It is controlled by motor neurons, giant fibre neurons, and possibly other 
neurons in the CNS (Ismail et al., 2015). Exploratory walking is a more complex locomotor 
behaviour and controlled by the central complex and mushroom bodies of the fly brain. 
Different parameters of this behaviour indicate motor neurons and muscle functions such as 
speed and walking distance; and decision-making processes, and thus CNS function, such as 
orientation (direction of walking), bout structure (length and frequency of bouts), and changes 
in walking direction (Ismail et al., 2015).   
Both systemic IIS mutants were long-lived, and results have shown ameliorated negative 
geotaxis senescence in both models (Ismail et al 2015). By comparison, neuronal-restricted IIS 
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reduction was sufficient to extend female lifespan only, suggesting that downregulating IIS in 
the CNS may be sufficient for lifespan extension. Despite the extension in female lifespan, 
there was no improvement in negative geotaxis in neuronal IIS reduction (Fig. 8). This suggests 
that the improvement in negative geotaxis is due to the effects on peripheral tissues rather 
than neural tissues (Ismail et al., 2015).  
  
Figure 8. Lifespan and behaviour senescence of female flies with ubiquitous (d2GAL/UAS-rpr 
and daGAL4/UAS-InRDN) or neuron specific (elavGAL4/UAS-InRDN) reductions in IIS 
A-C: The long-lived flies with d2GAL/UAS-rpr mutant have shown improved negative geotaxis 
decline but no difference in their exploratory walking decline. D-F: The long-lived flies with 
daGAL4/UAS-InRDN mutant have shown improved negative geotaxis decline but no change in 
their exploratory walking decline. G-I: The long-lived flies with neuronal-specific IIS reduction 
(elavGAL4/UAS-InRDN) has shown no change in negative geotaxis senescence but accelerated 
exploratory walking senescence. Rotation frequency is one parameter for exploratory walking 





For exploratory walking, there was no improvement of this behavioural decline in long-lived 
systemic IIS flies while there was a detrimental effect on behavioural decline in the neuronal 
IIS reduction models (Fig. 8). The results have shown that IIS-regulated lifespan extension can 
occur in the presence of normal, ameliorated, or accelerated locomotor senescence and 
different locomotive behaviours are independently regulated by IIS (Ismail et al., 2015). 
However, the exact role of IIS in CNS function and ageing still remains unclear and further 
research is needed to answer the question whether the negative effects on behaviour 
senescence is a result of accelerated ageing or detrimental functional effects on neurons.  
On the other hand, sleep is another universally conserved behaviour and it is considered to be 
controlled by the CNS (Cirelli and Bushey, 2008). Sleep has been extensively investigated in 
Drosophila and shows fundamental characters of sleep that are similar to mammals. The 
important similarities include the requirement for dopaminergic and GABAergic signalling, a 
circadian timing mechanism, the impact of homeostatic factors, extended periods of 
quiescence, and elevated arousal threshold (Catterson et al., 2010). Ageing is associated with 
reduced duration of sleep and reduced sleep efficiency, thus, ageing-related changes in sleep 
patterns are intensively under investigation. Flies show ageing-related changes in sleep that 
are similar to humans including the increase in sleep fragmentation (more walking periods 
during sleep), the reduction in total sleep time, the decline in the arousal threshold (easier to 
wake up), and the decline in the recoverability of sleep after sleep deprivation (Vienne et al., 
2016). Moreover, insulin-producing cells (mNSCs) are involved in the regulation of nutrition 
and sleep and in fact, day and night sleep are differentially regulated by nutrient levels and 
distinct mechanisms (Broughton et al., 2010). Drosophila sleep is characterised as a bimodal 
pattern that peaks both at midday and midnight and can be divided into daytime sleep and 
nighttime sleep. Two other type of neurons, dorso-lateral neurons (LNds) and PDF-positive 
ventrolateral neurons (LNvs), are also DILP-producing cells that regulate nighttime sleep and 
daytime sleep respectively; and daytime sleep is more sensitive to insulin signalling (Cong et 
al., 2015). A recent study has reported that lowered IIS can ameliorate age-related sleep 
fragmentation in DILP2-3, 5 mutants and daGAL4/UAS-InRDN flies, suggesting that reduced IIS 
improves different aspects of age-induced deterioration through multiple pathways 
(Metaxakis et al., 2014). However, like humans, fly sleep also shows significantly 
interindividual variability within the same fly population and sleep can be influenced by many 




2.8 Aims and Objectives 
The aim of this project is to continue the investigation of the role of IIS in the neuronal ageing 
and function of Drosophila by using an alternative transgene model (PTEN) in comparison to 
the previous results on InRDN model.  
The objectives are to determine the role of reduced IIS in development and adulthood in the 
modulation of longevity and behavioural senescence by reducing IIS in neurons throughout 
lifespan or in adulthood respectively. The objectives are also to answer the question of 
whether the effects of reduced IIS on behavioural senescence are due to functional changes 
or ageing changes. 
2.9 Research Design 
Based on previous studies, it is hypothesized that reduced IIS is not always beneficial to the 
neural circuitry underlying locomotor behaviours despite increasing lifespan. Therefore, this 
project aims to answer if the effects of neuron-specific IIS reduction on behavioural 
senescence are restricted to the modulation of the insulin receptor or not by using an 
alternative transgenic model (elavGAL4/UAS-PTEN). To investigate whether the IIS-induced 
effects on behavioural senescence are due to effects on neuronal function or neuronal ageing, 
an inducible system, GeneSwitch system, was used to control the period of IIS reduction and 
allow for the restoration of IIS function prior to behavioural testing. By using the inducible 
system, IIS reduction was restricted to adulthood only (RU486-elavGS/UAS-PTEN). The role of 
IIS in neuronal function and ageing during development and adulthood was determined by 
comparing the effect of constitutive IIS knockdown (elavGAL4/UAS-PTEN) with adult specific 
knockdown (elavGS/UAS-PTEN+/-RU486) and adult-specific knockdown with recovery 
(elavGS/UAS-PTEN+RU486 and 5-day recovery without RU486).   
Lifespan was measured of each genotype flies, along with female fecundity, negative geotaxis, 
exploratory walking, and sleeping behaviours were measured every 10 days throughout their 
lifespan as the indications of their behavioural and functional senescence. To identify the 
effects of neuronal IIS reduction elsewhere in the body, stress resistance test (starvation and 
oxidative stress) and body content (glycogen and lipid content) were also measured in each 
genotype. For further cellular identification, an apoptosis assay was performed where fly brain 




3. Material and methods 
3.1 The Preparation and Maintenance of Drosophila Melanogaster  
3.1.1 Genetic Background and Maintenance of Drosophila Melanogaster Stock  
In this project, the UAS-GAL4 system was used to modulate the level of insulin signalling in 
Drosophila Melanogaster. To study the effect of reduced insulin signalling throughout lifespan 
or in adulthood only, two different GAL4 drivers were used and the UAS-GAL4 crosses were 
set up as shown in Tab. 1. 
Throughout lifespan Adulthood only 
Experimental Control Experimental Control 
elavGAL4 (♀) X UAS-
PTEN (♂) 
elavGAL4 (♀) X wDah 
(♂) 
elavGS X UAS-PTEN 
(on drug) 
elavGS X wDah (on 
drug) 
wDah X UAS-PTEN elavGS X UAS-PTEN 
(off drug) 
elavGS X wDah (off 
drug) 
Table 1. The UAS-GAL4 crosses in the experiment. 
The different fly stocks used throughout the experiments are shown as in Tab. 2. All lines were 
backcrossed into a white Dahomey (wDah) wild-type for six generations before the experiments 
to control the genetic background. This wild-type background strain is an outbred strain, 
originally obtained in Africa (Benin) in the 1970s, maintained, then mutated with a partial 
deletion in the white (w) gene which leads to white eyes (Ziehm et al., 2013). All fly stocks 
were maintained in individual Drosophila bottles with sponge bungs plugged in. The bottles 
were changed every 3 weeks and kept at room temperature in natural light. 
Type Name Acronym Source References 
UAS PTEN 
overexpression 
UAS-PTEN Ernst Hafen Ikeya et al 
(2009) 
GAL4 Pan-neuronal elavGAL4 Bloomington 
stock no. 25750 




elavGS Partridge lab, 
UCL 
Rogers et al 
(2012) 




Table 2. The list of different fly stocks used throughout the project. 
Stock number refers to Bloomington Stock Centre.                                  
3.1.2 The Setup of Experimental Drosophila Melanogaster Flies Using UAS-GAL4 Crosses  
As female flies tend to store sperms for days after copulation, to control the production of 
required genotype offspring for this experiment, virgin female flies were collected from the 
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stock first for all genetic crosses. Within 6-8 hours after eclosion, female flies are usually 
immature and unreceptive to male courtship that can be distinguished from older flies based 
on their pale colour. Collected virgin females were kept as 10 in each vial for 3-4 days to check 
for any fertilized eggs. 3-4 days old virgin females were mated with different males as shown 
in Tab. 1 in vials for 4 hours before transferring into Drosophila cages. For optimal egg 
collection, grape juice plates (Tab. 3) with live yeast paste in the centre were used as food and 
changed every 24 hours for 3 days. Eggs from these plates were collected with 1% PBS and 
transferred into Drosophila bottles (180µL/bottle) with a widened pipette tip. As soon as 
eclosion, flies were sorted into vials from the bottles with 10 flies per vial and females and 
males separately. Therefore, all flies used in all behavioural assays should be un-mated 
females and males. Different groups of flies were kept for lifespan and each behavioural assay 
and fresh flies were used for analysis at each time point. 
3.1.3 The Maintenance of Experimental Drosophila Melanogaster Flies and Drosophila 
Media  
All flies during the experiment were maintained in an incubator with 25°C temperature, 70% 
humidity, and a 12h dark/light lighting cycle. All vials were changed every 3-4 days and kept 
flat on their side to avoid flies sticking in the food. Unless otherwise stated, the standard 
sugar/yeast food (Tab. 3) was used in the maintenance of fly stocks and experimental flies 
both in Drosophila bottles and vials throughout the project. For elavGS flies, they were 
maintained on standard Drosophila food then transferred into RU486 food (Tab. 3) on day 4. 
Based on previous studies (Osterwalder et al., 2001), to achieve the optimal effects of RU486 
in GeneSwitch system on lifespan extension, this project aimed for the concentration of RU486 
at 200mM. Through calculations, 50µl of 3.2mg/ml RU486 solution was added into each fly 
vial containing approximately 2-3ml of standard Drosophila food. All RU486 food was prepared 
at least 48 hrs before usage.  To test the behaviours of elavGS flies with a recovery period, flies 























Water (ml) 700 1000 160 700 1000 
(grape 
juice) 
Agar (g) 15 15 3 15 16 
Sugar – 
sucrose (g) 
50 0 10 50 0 
Yeast – MP 
Biomedicals 
(g) 
100 0 0 100 0 
Water at the 
end (ml) 
170 0 6.7 170 0 
30% H2O2 (ml) 0 0 33.3 0 0 
Nipagin (ml) 30 30 0 30 0 
Propionic Acid 
(ml) 
3 3 0 3 0 
RU486 (µl) 0 0 0 50 0 
Table 3. The recipes of all Drosophila media in the project 
As for the procedures of standard Drosophila media, agar powder was firstly added into 
lukewarm water then boiled for full dissolution. 0.5xS/1.0Y (50g/l sugar and 100g/l yeast) was 
the ratio of sugar and yeast used in this recipe and the sugar-yeast mixture was constantly 
stirred and fully mixed with boiled agar solution before boiling again. After boiling, the well-
mixed solution was removed from heat and cold water was added. Further nipagin and 
propionic acid were added as preservatives when the mixture was cooled down to 
approximately 60°C (nipagin was prepared by dissolving 100g nipagin powder in 1L ethanol). 
The mixture was then poured into vials or bottles and covered with a breathable fabric to set 
at room temperature for at least 1 day before using.   
3.2 Lifespan 
After eclosion in Drosophila bottles, un-mated flies of each genotype were sorted into vials as 
10 flies per vial (females and males separately). N=100 or 150 was used in the lifespan 
experiments. Flies were transferred into fresh food vial every 3 days and dead flies were 
counted each time. The survival curve was plotted as the proportion of surviving flies vs age. 
3.3 Fecundity 
The number of eggs laid by female flies in 24 hours was recorded for the indication of their 
fecundity function. Before counting, female flies were transferred into the fresh vial and the 
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number of eggs laid in each vial was counted after 24h. N=100 was used in this assay and 
fecundity was measured every 10 days throughout the lifespan. The data was presented as 
the average number of eggs laid by individual female per day. 
3.4 Negative Geotaxis 
Flies were transferred from each vial into a serological pipette (25cm long and 1.5cm 
diameter), aiming for 10 flies in each serological pipette and 3 pipettes for each genotype 
(N=30). Negative geotaxis was tested every 10 days throughout the lifespan in the 25°C 
temperature and 70% humidity incubator at 2pm each time. Flies were banged down to the 
bottom of pipettes at the start and observed for 45 seconds. The number of flies reaching to 
the ‘top’ (more than 10cm from the bottom) and the number of flies staying at the ‘bottom’ 
(less than 1cm from the bottom) were counted (both were indicated by the red lines on the 
serological pipette). Three repeats were carried out for each pipette and the data was 
presented as their performance index (1 2⁄ ∗
𝑁𝑡𝑜𝑡𝑎𝑙+ 𝑁𝑡𝑜𝑝− 𝑁𝑏𝑜𝑡𝑡𝑜𝑚
𝑁𝑡𝑜𝑡𝑎𝑙
) (as described in Rival et al., 
2004). 
3.5 Exploratory Walking  
This behaviour assay was performed every 10 days throughout the lifespan in the 25°C 
temperature and 70% humidity incubator at 1 pm every time. In the experiment, individual 
flies (N=15 or 16) were aspirated from their vials into a 40mm diameter and 10mm height 
circular area (Ismail et al). 2% agar plates were underneath and their activities inside the 
restricted area were video recorded for 15mins. The videos were then analysed with 
EthoVision XT video tracking software (Noldus) and different parameters of their walking 
behaviours were plotted into graphs. 
3.6 Sleeping Behaviour 
Sleeping behaviours were also tested every 10 days throughout the lifespan in the 25°C 
temperature and 70% humidity incubator with 12h light/dark cycle for 4 days. Flies were 
knocked out by CO2 and individual flies (N=15) were transferred into a Trikinetics Drosophila 
Activity Monitor tubes. Different types of Drosophila media were provided at the end of the 
monitor tubes based on their genotypes. Their activities inside the incubator were monitored 
with a 1min bins for 4 days and no movement within 5 consecutive bins was classified as sleep. 
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The data of day 2-3 were analysed using the BeFLY! Excel plug-in and different parameters of 
their sleeping behaviours were plotted into graphs.  
3.7 Starvation Resistance  
To test fly’s resistance to starvation, flies were kept as 10 / vial in standard food or RU486 food 
vial as normal and transferred into starvation experiment food with 0xSY (Tab. 3) on day 10. 
N=100 was used in this experiment and dead flies were counted every day. The survival curve 
was plotted as thr proportion of surviving flies vs age. 
3.8 Oxidative Stress Resistance  
Flies were kept as 10 / vial in standard food or RU486 food vial as normal and transferred into 
H2O2 oxidative stress experiment food (Tab. 3) on day 10. N=100 was aimed in this experiment 
and dead flies were counted twice a day (10 am and 5 pm respectively). The survival curve was 
plotted as the proportion of surviving flies vs age. 
3.9 Lipid and Glycogen Assay 
The flies were sorted into 10 / vial after eclosion and kept on standard or RU486 food vial until 
frozen at day 10 with liquid nitrogen (20 flies / Eppendorf tube). Firstly, individual flies were 
weighed and transferred into a separate Eppendorf tube. 100µl of the saturated Na2SO4 
solution was added into each tube to homogenise the fly, absorb and precipitate glycogen. 
1ml of chloroform: methanol (1:1) solution was added then to extract lipids out. The mixture 
was inverted several times gently and centrifuged 5mins at 6000 rpm to separate the lipid 
supernatant and glycogen pellet. 
Secondly, for lipid extraction and determination, the supernatant containing lipids was 
transferred into new Eppendorf tubes and evaporated on 70°C heat block under a fume hood. 
Fully dried oily residues were resuspended in 200ml of conc H2SO4 and then heated at 90°C 
for 10mins. After briefly cooled on ice, 1ml of vanillin solution (Tab. 4) was added into each 
tube and mixed well for full-colour development. 200µl of each sample was loaded onto a 
microassay plate and the absorbance was measured at 490nm using a Tecan infinite M200Pro 
spectrophotometer within 30mins of the colour development. The concentration of each 




Thirdly, Eppendorf tubes containing only glycogen pellets were fully dried in air or heating at 
90°C briefly before further steps to determine glycogen. 1ml of anthrone solution (Tab. 4) was 
added into the glycogen pellet and then incubated at 90°C for 20mins. The mixture was 
inverted several times in between to achieve the full dissolution of all pellets and the colour 
was developed during that period. 200µl of each sample was loaded onto a microassay plate 
and the absorbance was measured at 620nm using a Tecan infinite M200Pro 
spectrophotometer. The concentration of each sample was determined against a standard 




Add sodium sulphate into 1L distilled water until saturated 
Chloroform: 
methanol solution 
Chloroform: methanol was 1:1 ratio in this solution 
Vanillin solution 1.2% vanillin in 68% orthophosphoric acid 
Anthrone solution 75mg anthrone in 53ml 70% H2SO4 or 75mg anthrone in 10ml 
MQ H2O and 39ml 98% H2SO4 
Soybean oil A concentration series of soybean oil (0.92g/ml) by diluting in 
chloroform: methanol (1:1), concentration at 0µg to 500µg range  
Glycogen A concentration series of glycogen solution prepared by 
dissolving and diluting glycogen powder in MilliQ water, 
concentration at 0µg to 500µg range 
Table 4. The preparation of all solutions used in this assay and all solutions were prepared fresh 
for each assay. 
3.10 Apoptosis Assay 
Chemicon ApopTag Fluorescein Direct In Situ Kit (S7160) was used to perform this assay. Fly 
brains were freshly prepared each time and dissected into 1% PBS on ice. Brains were fixed in 
1% PFA (diluted in PBS) for 10mins at room temperature then washed in PBS three times for 
5mins each time. For permeabilization, brains were post-fixed in cooled ethanol: acetic acid 
(2:1) for 5mins at -20°C and washed in PBS twice for 5mins each afterwards. Equilibration 
Buffer (13µl per cm2) was applied for at least 10 seconds before removing and Working 
Strength TdT enzyme (Tab. 5) was immediately added to incubate in dark and humidified 
chamber at 37°C for 1hr. The mixture was then agitated for 15secs in Working Strength 
Stop/Wash Buffer (Tab. 5), incubated for 10mins at room temperature, and washed in PBS 
three times for 1mins each. In the meantime, an aliquot of Anti-digoxigenin conjugate was 
removed from the freezer and warmed up to room temperature in dark. Warmed Working 
Strength Anti-Digoxigenin conjugate (13µl per cm2) was added into the tissues and incubated 
in dark and humidified chamber at room temperature for 30mins. Finally, brains were washed 
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in PBS four times for 2mins each, mounted with DAPI, sealed with a coverslip, and stored at -
20°C before further use. All brains were observed under a confocal microscope where Z-stacks 
were performed. All images were further analysed by Image J and the whole area of apoptotic 




Mix 77µl Reaction Buffer with 33µl TdT (glycerol stock in -20°C), 
vortex, and store on ice for up to 6hrs 
Working Strength 
Stop/Wash Buffer 
Mix 2ml Stop/Wash Buffer with 34ml dH2O and store at 4°C for 




Mix 68µl Blocking Solution with 62µl Anti-Digoxigenin Conjugate, 
vortex, and store on ice for up to 3hrs (protect from light) 
Table 5. The preparation of all solutions used in this assay and all solutions were prepared fresh 
for each assay. 
3.11 Statistical Analysis 
Lifespan data were subjected to survival analysis (Log-rank tests) in Excel and plotted as 
survival curves (survival flies vs age). All statistical analyses of other data (fecundity, negative 
geotaxis, exploratory walking, and sleeping behaviour) were performed in the JMP (version 8) 
software (SAS Institute). The distribution of studentized residuals of each set data was tested 
for normal distribution and the outliers were removed if appropriate. Two-way analyses of 
variance (ANOVA) comparing by genotypes and by age were performed and planned 
comparisons of means performed using T-test (between 2 pairs, p<0.05) or Tukey-Kramer HSD 




4. Results-The Effect of Constitutive IIS Reduction Using 
elavGAL4/UAS-PTEN on Drosophila Ageing and Behavioural 
Senescence 
4.1 Introduction  
Previous studies have found that systemic reduction of IIS can extend lifespan and improve 
some measures of health and function in different model organisms, ranging from 
invertebrates to mammalians (Fontana et al., 2010). The evolutionary role of the IIS pathway 
in ageing has been confirmed, yet, little is known about the role of IIS in neuronal function and 
ageing (Broughton and Partridge, 2009). However, there is growing evidence that reducing IIS 
is not always beneficial to behavioural senescence. A recent study in our lab using an Insulin 
Receptor dominant negative transgene to reduce IIS in neurons found that long-lived flies did 
not show an amelioration of locomotor senescence (Ismail et al., 2015). In this project, an 
alternative transgene to reduce IIS in neurons was used (elavGAL4/UAS-PTEN) to further study 
the role of IIS in the nervous system and behavioural senescence. As mentioned above, 
elavGAL4 is a pan-neuronal driver and drives the expression of UAS-PTEN. PTEN functions as 
a phosphatase which downregulates IIS signalling via dephosphorylation of PIP3 to PIP2. The 
effect of reduced IIS on flies was measured by lifespan, fecundity, and behavioural senescence 
including locomotor behaviours (negative geotaxis and exploratory walking) and sleeping 
patterns. The performance of the experimental flies (elavGAL4/UAS-PTEN) was compared with 
the performance of the two control genotypes (elavGAL4/+ and UAS-PTEN/+) and to exclude 
any negative effects caused by the drivers (elavGAL4 or UAS-PTEN). In addition, previously in 
our lab, the validations of each genetically modified Drosophila lines were performed. For 
GAL4 drivers, the virgin GAL4 females were crossed with UAS-MCD8-GAL4 males. Their brains 
were dissected, fixed, and the GFP expression pattern was examined under a confocal 
microscopy validating the GAL4 lines only expressed in the appropriate neurons. For UAS 
drivers, UAS-PTEN flies were crossed with the systemic daGAL4 driver to ubiquitously express 
UAS lines in the whole body. All flies weighed less than the control flies and females had lower 
fecundity, consistent with previous results of IIS effects on fly growth and fecundity and 
confirming the effectiveness of PTEN overexpression. 
4.2 Lifespan and Fecundity 
Pan-neural IIS reduction shortened the lifespan of males but had no effect on females.  
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Two replicate lifespan experiments were performed for both females and males with N=100 
for each experiment and each replicate presented similar results. The fecundity of the females 
was measured every 10 days alongside each lifespan experiment (N=100). In both experiments, 
experimental female flies with reduced IIS in neurons showed a normal decline in the survival 
rate compared to controls (Fig. 9A&C). Female fecundity showed a significant decline with age 
in control flies and there was no difference between the experimental flies and control flies 
(Fig. 9B&D). In contrast, reduced IIS in neurons significantly shortened the lifespan of males in 
both replicate experiments (Fig. 9E&F). 
 
Figure 9. Lifespan and fecundity of elavGAL4/UAS-PTEN flies. 
A-D: The lifespan and fecundity of elavGAL4/UAS-PTEN females (N=100) in 2 replicate 
experiments. Transgenic elavGAL4/UAS-PTEN females with IIS reductions in all neurons had 
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normal lifespan and fecundity compared to control flies (p>0.05 by log-rank test). E-F: The 
lifespan of elavGAL4/UAS-PTEN males (N=100) in 2 replicate experiments. elavGAL4/UAS-PTEN 
males with IIS reductions in all neurons were significantly short-lived compared to control flies 
(p<0.05 by log-rank test). Lifespan data was analysed by log-rank test and fecundity data at 
individual time points by genotype or by age were analysed by two-way ANOVA followed by 




4.3 Locomotor behavioural Senescence – Negative Geotaxis and Exploratory Walking 
Reduced IIS in neurons had no effect on behavioural senescence in both males and females. 
Negative geotaxis is a reflex motor behaviour of the fruit flies and it is a part of their escape 
behaviour. Once flies are startled and dropped down to the bottom, they respond by climbing 
up against gravity. This behaviour can be used to indicate the effects of treatments on physical 
strength and brain function. Exploratory walking is a more complex locomotor behaviour of 
flies with multiple quantifiable parameters that indicate not only muscle strength (such as 
total distance or velocity) but also decision-making processes and thus CNS function (such as 
rotation frequency or duration in central zone) (Ismail et al., 2015). Both locomotor behaviours 
show age-related changes indicating declines in function. The performances of negative 
geotaxis and parameters of exploratory walking including total distance, walking duration, 
rotation frequency, and velocity decline significantly with age.  
In control females, negative geotaxis and exploratory walking showed the expected age-
related declines (Figure 10). When reducing IIS in the neurons, elavGAL4/UAS-PTEN female 
flies showed a normal decline in both locomotor behaviours compared to the control flies (Fig. 
10A-H). There was a small negative effect on experimental flies at young age points but the 
difference between the experimental flies and control flies was not significant (observed in Fig. 
10 A, C, E, & F). On the other hand, exploratory walking experiments and negative geotaxis 
were also performed with elavGAL4/UAS-PTEN males every 10 days throughout the lifespan. 
Despite the shortened lifespan of experimental flies (Fig. 9E&F), there was no effect on 
behavioural senescence of the experimental flies compared to the control flies in both 






Figure 10. Exploratory walking and negative geotaxis of elavGAL4/UAS-PTEN females. 
A-G: Exploratory walking senescence for a cohort of female flies of the indicated genotypes 
(N=15). A: Female mean total distance walked (mm) vs age. B: Female mean duration in 
central zone (secs) vs age. C: Female mean walking duration (secs) vs age. D: Female mean 
number of movement bouts vs age. E: Female mean frequency of rotations (change in walking 
direction) vs age. F: Female mean velocity (mm/sec) vs age. G: Female mean latency of first 
rotation (first change of walking direction) (secs) vs age. H: Negative geotaxis performance 
index (PI) over the lifespan of elavGAL4/UAS-PTEN female flies compared to elavGAL4/+ and 
UAS-PTEN/+ controls, N=3 (groups of 10 flies) for each genotype. All data are shown as mean 
value for each parameter ±SEM. All data at individual time points by genotype or by age were 
analysed by two-way ANOVA followed by post hoc means comparisons using Tukey HSD and 




Figure 11. Exploratory walking and negative geotaxis of elavGAL4/UAS-PTEN males 
A-G: Exploratory walking senescence for a cohort of male flies of the indicated genotypes 
(N=15). A: Male mean total distance walked (mm) vs age. B: Male mean duration in central 
zone (secs) vs age. C: Male mean walking duration (secs) vs age. D: Male mean number of 
movement bouts vs age. E: Male mean frequency of rotations (change in walking direction) vs 
age. F: Male mean velocity (mm/sec) vs age. G: Male mean latency of first rotation (first 
change of walking direction) (secs) vs age. H: Negative geotaxis performance index (PI) over 
the lifespan of elavGAL4/UAS-PTEN male flies compared to elavGAL4/+ and UAS-PTEN/+ 
controls, N=3 (groups of 10 flies) for each genotype. All data are shown as mean value for 
each parameter ±SEM. All data at individual time points by genotype or by age were analysed 
by two-way ANOVA followed by post hoc means comparisons using Tukey HSD and no 




4.4 Sleeping Behaviours 
Reduced IIS in neurons had an early age negative effect on males’ night-time sleep.  
Sleep is another behaviour that is controlled by the CNS and it is essential for all species and 
influences different physiological processes (Cirelli and Bushey, 2008). Flies’ activities are 
tightly regulated by circadian rhythms in a 12:12 hr light: dark (LD) cycle such that they exhibit 
two peaks of activity, morning and evening (Dubowy and Sehgal, 2017). Based on the bimodal 
pattern of Drosophila sleep, their sleep can be divided into daytime sleep and night sleep 
(Cong et al., 2015). The sleep patterns in flies have also been shown to deteriorate with age 
and become more fragmented with age like in humans – sleep duration becomes shorter and 
more often being interrupted by waking periods (Robertson and Keene, 2013). However, this 
senescence is very variable and different studies have not always seen the same kind of 
fragmentation with age. In this project, this behaviour is mainly used to assess the senescence 
of sleep parameters as measures of brain function with age and to compare the brain function 
of different genotypes. 
Two replicate sleep behaviour experiments were performed on elavGAL4/UAS-PTEN females 
and the results are presented in Figures 12 and 13. In the first sleep experiment, the sleep 
fragmentation with age phenotype was not clearly shown in flies and only a few parameters 
showed age-related changes (Fig. 12). In control flies, total daily activity showed a significant 
increase with age; total sleep in light, average bout length in dark, and average bout length in 
light showed a significant decline with age. Other parameters including total sleep per day, 
total sleep in dark, bouts of sleep in dark, and bouts of sleep in light showed fluctuations over 
the five age points but no significant changes with age. The experimental flies showed a 
normal senescence of sleeping behaviours indicating that expression of PTEN in neurons had 
no effect on the ageing of sleep behaviour. However, interestingly it was observed that 
experimental flies appeared to be less active and slept more at young ages (Fig. 12 A, I, & J). 
The significant difference in the total sleep per day at 18 days old was a result of a specific 
effect on daytime sleep which showed an increase in sleep bout length but not the number of 





Figure 12. Daily activity and sleep pattern of elavGAL4/UAS-PTEN females. 
A: Female mean total activity in 24hrs (mins) vs age. I: Female total sleep in 24 hrs (mins) vs 
age. B-D: Nighttime sleep of female flies of the indicated genotypes. J-L: Daytime sleep of 
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female flies of the indicated genotypes. B: Female mean total sleep in 12hrs dark (mins) vs 
age. C: Female mean total number of sleep bouts in 12hrs dark vs age. D: Female average 
bout length in 12hrs dark (mins) vs age. J: Female mean total sleep in 12hrs light (mins) vs age. 
K: Female mean total number of sleep bouts in 12hrs light vs age. L: Female average bout 
length in 12hrs light (mins) vs age. N=15 and all data are shown as mean value for each 
parameter ±SEM. All data at individual time points by genotype or by age were analysed by 
two-way ANOVA followed by post hoc means comparisons using Tukey HSD. * indicates 




In the second sleep pattern experiment, the age-related deteriorations in sleep behaviour 
were clearer and sleep became fragmented with age (Fig. 13). Total daily activity and bouts of 
sleep in light showed a significant increase with age; significant age-related declines were 
observed in parameters including total sleep in light, bouts of sleep in dark, and average bout 
length in light. The senescence of activity and sleep patterns of the experimental females does 
not appear to be significantly different from the control groups in any parameters and the 





Figure 13. Daily activity and sleep pattern of elavGAL4/UAS-PTEN females. 
A: Female mean total activity in 24hrs (mins) vs age. I: Female total sleep in 24 hrs (mins) vs 
age. B-D: Nighttime sleep of female flies of the indicated genotypes. J-L: Daytime sleep of 
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female flies of the indicated genotypes. B: Female mean total sleep in 12hrs dark (mins) vs 
age. C: Female mean total number of sleep bouts in 12hrs dark vs age. D: Female average 
bout length in 12hrs dark (mins) vs age. J: Female mean total sleep in 12hrs light (mins) vs age. 
K: Female mean total number of sleep bouts in 12hrs light vs age. L: Female average bout 
length in 12hrs light (mins) vs age. N=15 and all data are shown as mean value for each 
parameter ±SEM. All data at individual time points by genotype or by age were analysed by 
two-way ANOVA followed by post hoc means comparisons using Tukey HSD and no significant 




In the sleeping behaviour experiment of males, clear, age-related deteriorations were 
observed in control males for some sleep parameters including the decline in total sleep in 
dark, total sleep in light, average bout length in dark, and average bout length in light; and the 
increase in bouts of sleep in dark and bouts of sleep in light (Fig. 14). The activity and sleep 
patterns of elavGAL4/UAS-PTEN males do not appear to differ significantly from the control 
groups at each age points. However, in males, the expression of PTEN in neurons resulted in a 
specific effect on nighttime sleep; total sleep in dark and average bout length in dark did not 
show a normal decline with age. An early age effect was found that the night-time sleep of 
elavGAL4/UAS-PTEN males was significantly shorter than the control groups and the average 
bout length in the dark appeared to be shorter as well (Fig. 14 B&D). This lack of age-related 





Figure 14. Daily activity and sleep pattern of elavGAL4/UAS-PTEN males. 
A: Male mean total activity in 24hrs (mins) vs age. I: Male total sleep in 24 hrs (mins) vs age. B-
D: Nighttime sleep of male flies of the indicated genotypes. J-L: Daytime sleep of male flies of 
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the indicated genotypes. B: Male mean total sleep in 12hrs dark (mins) vs age. C: Male mean 
total number of sleep bouts in 12hrs dark vs age. D: Male average bout length in 12hrs dark 
(mins) vs age. J: Male mean total sleep in 12hrs light (mins) vs age. K: Male mean total number 
of sleep bouts in 12hrs light vs age. L: Male average bout length in 12hrs light (mins) vs age. 
N=15 and all data are shown as mean value for each parameter ±SEM. All data at individual 
time points by genotype or by age were analysed by two-way ANOVA followed by post hoc 
means comparisons using Tukey HSD. * indicates significant differences (p<0.05) between the 





In summary of the results on the elavGAL4/UAS-PTEN transgenic flies, females with 
constitutive IIS reduction in neurons showed a normal lifespan, fecundity, and behavioural 
senescence. However, an early-age detrimental effect was observed in some behavioural 
parameters. In contrast, males with a constitutive IIS reduction in neurons were significantly 
short-lived compared to control flies. Despite the shortened lifespan, males presented a 
normal senescence of most behavioural parameters. In some parameters, males did not show 
the normal age-related decline which may have been the result of a potential young-age 
negative effect. Together, the data show that reducing IIS in neurons via expression of UAS-
PTEN is not beneficial to survival and actually shortens the lifespan of males, in contrast to the 
effect of expression of the UAS-InRDN transgene. However, the data indicate that similar to 
previous studies, lifespan and behavioural senescence can be disconnected and reduced IIS in 




5.  Results – The Effect of Inducible IIS Reduction Using RU486-
elavGS/UAS-PTEN on Drosophila Ageing and Behavioural 
Senescence 
5.1 Introduction 
Considering the role of IIS signalling in cell growth, cell division, gene expression, and other 
fundamental functions, it was suspected that IIS reduction throughout lifespan may cause 
some negative effects during developmental stages and may have been the cause of the 
young-age behavioural effects observed in elavGAL4/UAS-PTEN flies and the lifespan effects. 
In the following experiments, the reduction of IIS was restricted to adult neurons only to 
exclude any negative effects during the developmental period and to compare the role of IIS 
signalling in neuronal function and ageing during adulthood and development. As mentioned 
above, the RU486-dependent inducible system, the GeneSwitch driver (elavGS), was used to 
control the timing of IIS reduction. To study the role of IIS signalling in adulthood period, 
experimental flies (RU486-elavGS/UAS-PTEN) developed into adulthood on normal food and 
were placed onto RU486 drug-containing food to reduce IIS after that to compare to normal 
flies without IIS reduction (elavGS/UAS-PTEN).  
In addition, Ismail et al. (2015) found a detrimental effect on locomotor senescence in the 
presence of lifespan extension in flies (elavGAL4/UAS-InRDN), suggesting that reduced IIS is not 
always beneficial to the neural circuitry underlying locomotor behaviours. Their results have 
raised the question of whether the effect of reduced IIS in neurons on behavioural senescence 
is the result of changes to neuronal ageing or neuronal function. To answer this question, a 
recovery experiment was conducted by giving RU486-elavGS/UAS-PTEN flies a recovery period 
before behavioural testing, allowing them to restore IIS function. Recovery periods were given 
in the recovery experiments by removing flies from the RU486 inducer 5 days before each time 
point of testing. Chronic experiments (flies without IIS restoration) and recovery experiments 
(flies with IIS restoration) were run separately but in parallel at the indicated time points to 
determine the effect of reduced IIS on neuronal function and ageing process. To exclude the 
effects on flies caused by the drug RU486, two additional control groups were tested in parallel 
(RU486-elavGS/+ and elavGS/+). 
5.2 Lifespan and Fecundity 
Adult-specific neural IIS reduction shortened the lifespan of males but not always of females  
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Lifespan experiments on RU486-elavGS/UAS-PTEN flies were repeated twice with N=100 and 
N=500 respectively, shown as Fig. 15 and 16. The fecundity of the females was measured every 
10 days alongside each lifespan experiment (N=100). In the first lifespan experiment, females 
with IIS reduction during adulthood was significantly short-lived (Fig. 15A). A detrimental 
effect was found at the young age on female fecundity, but females also showed a recovery 
from the negative effect at the older age and a normal decline in fecundity with age (Fig. 15B). 
The effect of the RU486 drug on flies was not detected in this experiment as flies on the drug 
were normally lived and had a normal female fecundity (Fig. 15C&D). The fecundity of flies on 
the drug at the first-time point appeared to be lower than normal flies but the difference was 
not statistically significant. Their fecundity declined normally with age, but a slightly higher 
fecundity was observed at the last age point.  
In the second lifespan experiment with a larger number of flies (N=500), experimental flies 
with IIS reduction during adulthood had a normal lifespan but their fecundity declined faster 
than the control flies and was significantly lower than control flies at several age points (Fig. 
16A&B). A drug effect on the flies was found in the control groups as flies on the drug were 
significantly short-lived and their fecundity appeared to decline faster than normal flies (Fig. 
16C&D). The difference between the two groups on fecundity was significant at several age 





Figure 15. Lifespan and fecundity of RU486-elavGS/UAS-PTEN females. 
A-B: The lifespan and fecundity of RU486-elavGS/UAS-PTEN females (N=100). Transgenic 
RU486-elavGS/UAS-PTEN females with IIS reductions in all neurons had a shorter lifespan and 
reduced fecundity compared to control flies. C-D: The lifespan and fecundity of RU486-
elavGS/+ females (N=100). RU486-elavGS/+ females had a normal lifespan but reduced 
fecundity compared to elavGS/+ flies. Lifespan data was analysed by log-rank test and 
fecundity data at individual time points by genotype or by age were analysed by two-way 
ANOVA followed by post hoc means comparisons using student’s t test. * indicates significant 
differences (p<0.05) between the RU486-elavGS/UAS-PTEN and elavGS/UAS-PTEN or between 






Figure 16. Lifespan and fecundity of RU486-elavGS/UAS-PTEN females. 
A-B: The lifespan and fecundity of RU486-elavGS/UAS-PTEN females (N=500). Transgenic 
RU486-elavGS/UAS-PTEN females with IIS reductions in all neurons had a normal lifespan but 
reduced fecundity compared to control flies. C-D: The lifespan and fecundity of RU486-
elavGS/+ females (N=500). RU486-elavGS/+ females had a normal lifespan but reduced 
fecundity compared to elavGS/+ flies. Lifespan data was analysed by log-rank test and 
fecundity data at individual time points by genotype or by age were analysed by two-way 
ANOVA followed by post hoc means comparisons using student’s t test. * indicates significant 
differences (p<0.05) between the RU486-elavGS/UAS-PTEN and elavGS/UAS-PTEN or between 




On the other hand, two lifespan experiments were also performed on RU486-elavGS/UAS-
PTEN male flies with N=100 and N=500 respectively. In both experiments, the lifespan of male 
flies with reduced IIS during adulthood was significantly shortened compared to control flies 
(Fig. 17A&B). To test any drug effects on flies, two lifespan experiments were performed in 
parallel on flies with or without the RU486 drug. However, one experiment showed no drug 
effect (normal-lived RU486-elavGS/+) while the other experiment showed a negative drug 





Figure 17. Lifespan of RU486-elavGS/UAS-PTEN males. 
A-B: Two replicate lifespan of RU486-elavGS/UAS-PTEN males (N=100, N=500). Transgenic 
RU486-elavGS/UAS-PTEN males with IIS reductions in all neurons had a shorter lifespan 
compared to control flies (p<0.05 by log-rank test). C-D: Two replicate lifespan of RU486-
elavGS/+ males (N=100, N=500). RU486-elavGS/+ males had a normal lifespan in C but shorter 




5.3 Locomotion Behavioural Senescence – Negative Geotaxis and Exploratory Walking 
Reduced IIS in adult neurons had detrimental effects on behavioural senescence but can be 
recovered from. 
Negative geotaxis and exploratory walking experiments were performed to study the effect of 
IIS reduction on neuronal ageing and function during adulthood. To answer the question about 
the detrimental effects on behavioural senescence as the result of ageing or function effects, 
recovery behavioural experiments were performed in parallel. In the recovery experiments, 
flies were placed onto RU486 once developed into adulthood and were removed from the 
inducing drug 5 days before behavioural testing to allow a period of restoration of IIS function. 
The results of flies on RU486 drug consecutively or with recovery period are compared in 
parallel. 
The performance of flies in exploratory walking and negative geotaxis declines with age such 
that old flies are less active and have a longer period to respond. As is shown in Fig. 18, 
significant age-related declines were observed in total distance, walking duration, rotation 
frequency, velocity, and negative geotaxis and the latency to first rotation time steadily 
increased with age. Age-related changes were not constant in the duration of flies staying in 
the central zone and their movement bouts. In females, flies with reduced IIS in adult neurons 
(RU486-elavGS/UAS-PTEN) had a normal behavioural senescence at early ages (up to 30). The 
performance of experimental females declined faster than control flies at older ages and the 
differences between the experimental and control flies were significant in some parameters 
of exploratory walking and negative geotaxis (Fig. 18A-H).  
On the other hand, by giving experimental flies a 5-day recovery period of IIS function, flies 
(RU486-elavGS/UAS-PTEN recovery) appeared to have recovered from the detrimental effects 
of IIS reduction and had a normal behavioural senescence compared to control flies (Fig. 18I-
P). There is a potential improvement on the latency to first rotation time in recovery flies: the 
deterioration in this parameter was slower in recovery flies but the differences between the 
recovery and control flies did not rise to statistically significant (Fig. 18O). The negative 
geotaxis performance of recovery flies was still worse than control flies at the older age but 
the difference between the recovery and control flies was less significant compared to flies 









Figure 18. Exploratory walking and negative geotaxis of RU486-elavGS/UAS-PTEN females with 
and without a recovery period. 
A-H: Exploratory walking and negative geotaxis senescence for a cohort of female flies of the 
indicated genotypes (without recovery period) (N=16). A: Female mean total distance walked 
(mm) vs age. B: Female mean duration in central zone (secs) vs age. C: Female mean walking 
duration (secs) vs age. D: Female mean number of movement bouts vs age. E: Female mean 
frequency of rotations (change in walking direction) vs age. F: Female mean velocity (mm/sec) 
vs age. G: Female mean latency of first rotation (first change of walking direction) (secs) vs 
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age. H: Negative geotaxis performance index (PI) over the lifespan of RU486-elavGS/UAS-
PTEN female flies compared to elavGS/UAS-PTEN controls, N=3 (groups of 10 flies) for each 
genotype. I-P: Exploratory walking and negative geotaxis senescence for a cohort of female 
flies of the indicated genotypes (with 5-day recovery period) (N=16). I: Female mean total 
distance walked (mm) vs age. J: Female mean duration in central zone (secs) vs age. K: Female 
mean walking duration (secs) vs age. L: Female mean number of movement bouts vs age. M: 
Female mean frequency of rotations (change in walking direction) vs age. N: Female mean 
velocity (mm/sec) vs age. O: Female mean latency of first rotation (first change of walking 
direction) (secs) vs age. P: Negative geotaxis performance index (PI) over the lifespan of 
RU486-elavGS/UAS-PTEN female flies compared to elavGS/UAS-PTEN controls, N=3 (groups of 
10 flies) for each genotype. All data are shown as mean value for each parameter ±SEM. All 
data at individual time points by genotype or by age were analysed by two-way ANOVA 
followed by post hoc means comparisons using student’s t test.  * indicates significant 




Experiments were also performed on control groups with or without the RU486 drug and 
presented as in Fig. 19. Flies on RU486 drug (RU486-elavGS/+) showed a normal decline in 
their behavioural performance with age comparing to the control group (elavGS/+). There 
were differences between the two groups found at one age point (age 30) in several 
parameters. However, there is no significant difference between the two groups at any other 
age points suggesting a normal behavioural senescence of flies on the drug.   
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Figure 19. Exploratory walking and negative geotaxis of RU486-elavGS/+ (control) females.  
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A-H: Exploratory walking and negative geotaxis senescence for a cohort of female flies of the 
indicated genotypes (N=16). A: Female mean total distance walked (mm) vs age. B: Female 
mean duration in central zone (secs) vs age. C: Female mean walking duration (secs) vs age. D: 
Female mean number of movement bouts vs age. E: Female mean frequency of rotations 
(change in walking direction) vs age. F: Female mean velocity (mm/sec) vs age. G: Female 
mean latency of first rotation (first change of walking direction) (secs) vs age. H: Negative 
geotaxis performance index (PI) over the lifespan of RU486-elavGS/+ female flies compared to 
elavGS/+ controls, N=3 (groups of 10 flies) for each genotype. All data are shown as mean 
value for each parameter ±SEM. All data at individual time points by genotype or by age were 
analysed by two-way ANOVA followed by post hoc means comparisons using student’s t test.  





In male flies, age-related changes were found in all parameters of exploratory walking and 
negative geotaxis: flies are less active with age and significant declines were found in total 
distance, walking duration, rotation frequency, velocity, and negative geotaxis; flies tended to 
stay longer in the central zone with age and the latency of first rotation time increased with 
age (Fig. 20). Experimental flies with IIS reduction throughout adulthood experienced 
accelerated declines in their behavioural senescence. The differences between the 
experimental flies and control flies became significant at older age points in nearly all 
parameters (Fig. 20A-H). On the other hand, in the parallel recovery experiments, a complete 
or partial recovery was observed in all parameters and the differences between the recovery 
flies and normal flies were not significant or less significant at older age point (Fig. 20I-P). A 
slight improvement in negative geotaxis performance was observed in recovery flies at the last 
age point (Fig. 20P). 
In the control groups testing the RU486 drug effects, control flies on the drug (RU486-elavGS/+) 
appeared to have a normal behavioural senescence comparing to flies without the drug. There 
were significant differences observed between the two groups at the older age point (Fig. 21). 
However, the overall faster declines in behavioural performance in Fig. 20A-H were not found 










Figure 20. Exploratory walking and negative geotaxis of RU486-elavGS/UAS-PTEN males with 
and without a recovery period. 
A-H: Exploratory walking and negative geotaxis senescence for a cohort of male flies of the 
indicated genotypes (without recovery period) (N=16). A: Male mean total distance walked 
(mm) vs age. B: Male mean duration in central zone (secs) vs age. C: Male mean walking 
duration (secs) vs age. D: Male mean number of movement bouts vs age. E: Male mean 
frequency of rotations (change in walking direction) vs age. F: Male mean velocity (mm/sec) vs 
age. G: Male mean latency of first rotation (first change of walking direction) (secs) vs age. H: 
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Negative geotaxis performance index (PI) over the lifespan of RU486-elavGS/UAS-PTEN male 
flies compared to elavGS/UAS-PTEN controls, N=3 (groups of 10 flies) for each genotype. I-P: 
Exploratory walking and negative geotaxis senescence for a cohort of male flies of the 
indicated genotypes (with 5-day recovery period) (N=16). I: Male mean total distance walked 
(mm) vs age. J: Male mean duration in central zone (secs) vs age. K: Male mean walking 
duration (secs) vs age. L: Male mean number of movement bouts vs age. M: Male mean 
frequency of rotations (change in walking direction) vs age. N: Male mean velocity (mm/sec) 
vs age. O: Male mean latency of first rotation (first change of walking direction) (secs) vs age. 
P: Negative geotaxis performance index (PI) over the lifespan of RU486-elavGS/UAS-PTEN 
male flies compared to elavGS/UAS-PTEN controls, N=3 (groups of 10 flies) for each genotype. 
All data are shown as mean value for each parameter ±SEM. All data at individual time points 
by genotype or by age were analysed by two-way ANOVA followed by post hoc means 
comparisons using student’s t test.  * indicates significant differences (p<0.05) between the 




Figure 21. Exploratory walking and negative geotaxis of RU486-elavGS/+ (control) males.  
A-H: Exploratory walking and negative geotaxis senescence for a cohort of male flies of the 
indicated genotypes (without recovery period) (N=16). A: Male mean total distance walked 
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(mm) vs age. B: Male mean duration in central zone (secs) vs age. C: Male mean walking 
duration (secs) vs age. D: Male mean number of movement bouts vs age. E: Male mean 
frequency of rotations (change in walking direction) vs age. F: Male mean velocity (mm/sec) vs 
age. G: Male mean latency of first rotation (first change of walking direction) (secs) vs age. H: 
Negative geotaxis performance index (PI) over the lifespan of RU486-elavGS/UAS-PTEN male 
flies compared to elavGS/UAS-PTEN controls, N=3 (groups of 10 flies) for each genotype. All 
data are shown as mean value for each parameter ±SEM. All data at individual time points by 
genotype or by age were analysed by two-way ANOVA followed by post hoc means 
comparisons using student’s t test. * indicates significant differences (p<0.05) between the 




5.4 Sleeping Behaviours 
Reduced IIS in adult neurons resulted in transient young age detrimental effects.  
Sleeping behaviours have shown age-related decline as flies’ sleep becomes more fragmented 
with age and more easily interrupted by their walking period. However, it is a complex 
behaviour and age-related change in each parameter has shown variations in different studies 
(Cirelli and Bushey, 2008). 
The parallel sleeping experiments with or without recovery period of females are presented 
on the left and right side respectively in Fig. 22. In the experiment of constitutive IIS reduction 
in adult neurons (RU486-elavGS/UAS-PTEN), age-related changes were not clearly shown in all 
parameters but in the decrease of bouts of sleep in dark and average bout length in light, and 
the increase of bouts of sleep in light (Fig. 22A-H). Comparing with the control flies, 
experimental flies were more active and shown a significant increase in total daily activity and 
a decrease in total sleep per day at several age points (Fig. 22A&B). An early age detrimental 
effect was observed in several parameters and the result of decreased total sleep per day may 
be the combination of decreased total sleep in dark and shorter bout length in dark. Despite 
the unclear trend of ageing effect on sleeping patterns, there were also differences between 
the experimental and control flies observed at older age points and some reached statistically 
significant.  
On the other hand, in the recovery experiment (RU486-elavGS/UAS-PTEN recovery), age-
related declines were found in total sleep in light and mean bout length in light; and age-
related increases were found in total sleep in dark, bouts of sleep in dark, and bouts of sleep 
in light (Fig. 22I-P). A certain recovery from the detrimental effect at the young age are shown 
in nearly all parameters. The differences between flies with IIS reduction and control flies at 
older age point became less significant or not significant in recovery flies. However, flies with 
a recovery period appeared to show a slightly faster deterioration in their activity and sleep 
patterns, shown as the differences in total sleep in dark, total sleep in light, bouts of sleep in 
dark, bouts of sleep in light, and average bout length in light.  
In the control experiment of drug effects, flies on the drug (RU486-elavGS/+) appeared to be 
more active in the total daily activity and have a less total amount of sleep per day (Fig. 
23A&B). Such differences were observed in the experimental groups as well (Fig. 22A&B), 
suggesting a negative effect of the RU486 drug on sleeping patterns. In other parameters of 
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sleeping, differences between the two control groups were found in a few time points while 
the majority of their activity and sleep patterns showed no difference. Taken together, some 
of the detrimental effects seen on experimental flies are the result of drug influence while 









Figure 22. Daily activity and sleep pattern of RU486-elavGS/UAS-PTEN females with and without 
a recovery period. 
A-H: Sleep behaviour senescence for a cohort of female flies of the indicated genotypes 
(without recovery period) (N=15). A: Female mean total activity in 24hrs (mins) vs age. B: 
Female total sleep in 24 hrs (mins) vs age. C: Female mean total sleep in 12hrs dark (mins) vs 
age. D: Female mean total sleep in 12hrs light (mins) vs age. E: Female mean total number of 
sleep bouts in 12hrs dark vs age. F: Female mean total number of sleep bouts in 12hrs light vs 
age. G: Female average bout length in 12hrs dark (mins) vs age. H: Female average bout 
length in 12hrs light (mins) vs age. I-P: Sleep behaviour senescence for a cohort of female flies 
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of the indicated genotypes (with 5-day recovery period) (N=15). I: Female mean total activity 
in 24hrs (mins) vs age. J: Female total sleep in 24 hrs (mins) vs age. K: Female mean total sleep 
in 12hrs dark (mins) vs age. L: Female mean total sleep in 12hrs light (mins) vs age. M: Female 
mean total number of sleep bouts in 12hrs dark vs age. N: Female mean total number of sleep 
bouts in 12hrs light vs age. O: Female average bout length in 12hrs dark (mins) vs age. P: 
Female average bout length in 12hrs light (mins) vs age. All data are shown as mean value for 
each parameter ±SEM. All data at individual time points by genotype or by age were analysed 
by two-way ANOVA followed by post hoc means comparisons using student’s t test. * 
indicates significant differences (p<0.05) between the RU486-elavGS/UAS-PTEN and 
elavGS/UAS-PTEN controls.  
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Figure 23. Daily activity and sleep pattern of RU486-elavGS/+ (control) females. 
A-H: Sleep behaviour senescence for a cohort of female flies of the indicated genotypes 
(N=15). A: Female mean total activity in 24hrs (mins) vs age. B: Female total sleep in 24 hrs 
(mins) vs age. C: Female mean total sleep in 12hrs dark (mins) vs age. D: Female mean total 
sleep in 12hrs light (mins) vs age. E: Female mean total number of sleep bouts in 12hrs dark vs 
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age. F: Female mean total number of sleep bouts in 12hrs light vs age. G: Female average 
bout length in 12hrs dark (mins) vs age. H: Female average bout length in 12hrs light (mins) vs 
age. All data are shown as mean value for each parameter ±SEM. All data at individual time 
points by genotype or by age were analysed by two-way ANOVA followed by post hoc means 
comparisons using student’s t test. * indicates significant differences (p<0.05) between the 




Turning to the sleeping experiments in males with IIS reduction throughout the adult period 
(RU486-elavGS/UAS-PTEN), robust ageing-related changes were only seen in the sleep bouts 
in light and bout length in both dark and light (Fig. 24A-H). The same early-age detrimental 
effects were found in males as well and the differences were especially significant in sleep 
bouts in dark and light, and mean bout length in light. In contrast to the control groups, a lack 
of ageing-induced changes was observed in the experimental flies, especially in bouts of sleep 
in light and average bout length in light, resulting in significant differences between the two 
groups at older age points (Fig. 24F&H).  
To answer the question whether this is ameliorated ageing or detrimental functional effects 
at the young age that flies cannot recover from, the recovery experiments were performed. 
RU486-elavGS/UAS-PTEN recovery flies showed a complete recovery from the negative effects 
in total sleep in light and partial recovery in bouts of sleep in dark and in light, and average 
bout length in light (Fig. 24I-P). The ageing-related changes were partially restored in some 
parameters and there is no difference between the two groups at older age points anymore. 
However, interestingly, a negative effect at the first age point was still found in some 
parameters, including total sleep per day, total sleep in dark, and average bout length in dark. 
In the examination of drug effects, the RU486-elavGS/+ flies behaved and aged similarly to the 
control flies overall and there were differences found between the two groups only at some 
age points (Fig. 25). The differences between RU486-elavGS/+ and elavGS/+ flies in total sleep 
per day and total sleep in light are similar to the differences seen in the experimental groups, 
suggesting a potential drug influence on these two parameters. However, other differences 
observed in the experimental groups were not found in these control flies, suggesting that 








Figure 24. Daily activity and sleep pattern of RU486-elavGS/UAS-PTEN males with and without a 
recovery period. 
A-H: Sleep behaviour senescence for a cohort of male flies of the indicated genotypes 
(without recovery period) (N=15). A: Male mean total activity in 24hrs (mins) vs age. B: Male 
total sleep in 24 hrs (mins) vs age. C: Male mean total sleep in 12hrs dark (mins) vs age. D: 
Male mean total sleep in 12hrs light (mins) vs age. E: Male mean total number of sleep bouts 
in 12hrs dark vs age. F: Male mean total number of sleep bouts in 12hrs light vs age. G: Male 
average bout length in 12hrs dark (mins) vs age. H: Male average bout length in 12hrs light 
(mins) vs age. I-P: Sleep behaviour senescence for a cohort of male flies of the indicated 
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genotypes (with 5-day recovery period) (N=15). I: Male mean total activity in 24hrs (mins) vs 
age. J: Male total sleep in 24 hrs (mins) vs age. K: Male mean total sleep in 12hrs dark (mins) 
vs age. L: Male mean total sleep in 12hrs light (mins) vs age. M: Male mean total number of 
sleep bouts in 12hrs dark vs age. N: Male mean total number of sleep bouts in 12hrs light vs 
age. O: Male average bout length in 12hrs dark (mins) vs age. P: Male average bout length in 
12hrs light (mins) vs age. All data are shown as mean value for each parameter ±SEM. All data 
at individual time points by genotype or by age were analysed by two-way ANOVA followed by 
post hoc means comparisons using student’s t test. * indicates significant differences (p<0.05) 





Figure 25. Daily activity and sleep pattern of RU486-elavGS/+ (control) males. 
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A-H: Sleep behaviour senescence for a cohort of male flies of the indicated genotypes (N=15). 
A: Male mean total activity in 24hrs (mins) vs age. B: Male total sleep in 24 hrs (mins) vs age. 
C: Male mean total sleep in 12hrs dark (mins) vs age. D: Male mean total sleep in 12hrs light 
(mins) vs age. E: Male mean total number of sleep bouts in 12hrs dark vs age. F: Male mean 
total number of sleep bouts in 12hrs light vs age. G: Male average bout length in 12hrs dark 
(mins) vs age. H: Male average bout length in 12hrs light (mins) vs age. All data are shown as 
mean value for each parameter ±SEM. All data at individual time points by genotype or by age 
were analysed by two-way ANOVA followed by post hoc means comparisons using student’s t 






To conclude the results on the inducible IIS reduction in adult neurons, RU486-elavGS/UAS-
PTEN females were normal-lived or slightly short-lived with normal fecundity (the apparent 
reduction in fecundity was RU486 drug-induced). RU486-elavGS/UAS-PTEN males were 
significantly short-lived in both experiments. Adult specific expression of PTEN resulted in an 
earlier decline in some parameters of locomotor behaviours (including total distance, walking 
duration, rotation frequency, velocity, latency to first rotation time, and negative geotaxis) 
compared to controls in both females and males. The differences between the performance 
of RU486-elavGS/UAS-PTEN and elavGS/UAS-PTEN flies were larger in males but both in 
females and males, the differences became significant at older age points. When flies were 
allowed to recover IIS function prior to behavioural testing, the detrimental effects were no 
longer observed or at least ameliorated in all parameters. 
On the other hand, the effect of inducible IIS reduction on sleeping behaviours is more 
complex and age-related changes in sleep patterns were not clear in our experiments. RU486-
elavGS/UAS-PTEN flies presented a drug-induced hyperactivity and reduced amount of sleep 
in both females and males. Adult specific expression of PTEN resulted in an early age 
detrimental effect observed in several parameters - different between females and males - 
including total sleep in dark, total sleep in light, bouts of sleep in dark, bouts of sleep in light, 
average bout length in dark, and average bout length in light. A lack of ageing-related changes 
was observed in RU486-elavGS/UAS-PTEN flies in some parameters and resulted in the 
significant differences at older ages between the RU486-elavGS/UAS-PTEN and elavGS/UAS-
PTEN flies. When flies were allowed to recover IIS function before behavioural testing, such 
young age effects were completely or at least partially recovered, and the age-related changes 
were observed in RU486-elavGS/UAS-PTEN flies again. 
Taken together, these data suggest that the detrimental effects of reduced IIS in neurons are 
due to functional changes that flies can recover from. However, no beneficial effects of 
reduced IIS on behavioural senescence were observed, even following a recovery period. This 
suggests that either PTEN expression resulted in long-lasting detrimental effects on neuronal 




6. Results – The Effect of IIS Reduction Using elavGAL4/UAS-PTEN 
and elavGS/UAS-PTEN on Stress Resistance, Energy Storage, and 
Cell Apoptosis 
6.1 Introduction 
The effect of IIS reduction in neurons on behavioural function and senescence during 
development and adulthood has been investigated above in lifespan, fecundity, and different 
behavioural analysis. However, in contrast to the lifespan extension induced by reduced IIS in 
literature, overexpression of PTEN in flies’ neurons throughout lifespan or adulthood is not 
beneficial to their lifespan, especially in males. Strong systemic reductions in IIS are known to 
be detrimental to lifespan due to the pleiotropic nature of the pathway (Ikeya et al., 2009; 
Karpac and Jasper, 2009). To investigate if over-expression of PTEN in neurons resulted in 
systemic effects in flies, phenotypes known to be influenced by IIS such as energy storage and 
stress resistance were measured.  
The IIS pathway is involved in glycogen synthesis, energy storage, glucose metabolism, and 
stress resistance. The pathway also interacts with other pathways such as TOR or JNK in 
response to nutrient levels and environmental stress (Broughton and Partridge, 2009). 
Previous research has reported that long-lived Drosophila mutants (IPC-ablated flies and 
dFOXO mutant) with systemic IIS reduction exhibited increased resistance to starvation and 
oxidative stress (Broughton et al., 2005; Slack et al., 2011). In addition to increased stress 
resistance, IPC-ablated flies also presented higher levels of trehalose, lipid and glycogen 
storages (Broughton et al., 2005). In other models, the downregulation of DILP2 was 
associated with an increased level of trehalose and resistance to starvation (Broughton et al., 
2008); while DILP2 loss-of-function mutant did not show any changes in lipid or glycogen levels 
(Grönke et al., 2010). Grönke et al. (2010) also reported the increased starvation resistance in 
DILP1-4 loss-of-function mutants but not in DILP2-3, 5 deletion mutants. 
Therefore, two stress resistance tests – starvation and oxidative stress – were performed with 
elavGAL4/UAS-PTEN and RU486-elavGS/UAS-PTEN flies to understand if the CNS is involved in 
the regulation of stress resistance or the role of neuronal-restricted IIS reduction on peripheral 
tissues. The levels of glycogen and lipid in the whole body were measured as another 
indication of the effects of IIS reduction in neurons on peripheral tissues. An apoptosis assay 
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was used to directly observing brain structure and apoptotic cells to examine the molecular 
changes caused by IIS reduction in neurons. 
6.2 Stress Resistance Test – Starvation and Oxidative Stress 
Pan-neural IIS reduction had no effect on stress resistance; adult-specific neural IIS reduction 
increased males’ starvation resistance.  
For starvation and oxidative stress test, 10-day old elavGAL4/UAS-PTEN flies were placed onto 
agar only or hydrogen peroxide food to induce starvation or oxidative stress. The lifespans of 
flies were measured as the indication of their resistance to environmental stress. The lifespans 
of elavGAL4/UAS-PTEN flies were compared with the lifespan of two control genotypes. In 
both females and males, there were no significant differences in their resistance to either 





Figure 26. Starvation and oxidative stress survival curve of elavGAL4 /UAS-PTEN flies. 
A-B: The survival curve of elavGAL4/UAS-PTEN females on starvation and hydrogen peroxide 
(oxidative stress) food (N=100). There was no significant difference between the experimental 
flies and the two control groups (p>0.05 by log-rank test). C-D: The survival curve of 
elavGAL4/UAS-PTEN males on starvation and hydrogen peroxide (oxidative stress) food 
(N=100). There was no significant difference between the experimental flies and the two 




For experiments on transgenic flies with the elavGS driver with adult specific PTEN expression, 
flies were allowed to develop normally from embryo to adult, and then RU486-elavGS/UAS-
PTEN and RU486-elavGS/+ adult flies were placed onto RU486 drug from day 1. All flies were 
then transferred to starvation or oxidative stress food accordingly on day 10. The starvation 
and oxidative stress experiments were performed twice for each gender with N=100 for each 
experiment.  
In terms of starvation resistance in females, in the first experiment, there was no significant 
change between the RU486-elavGS/UAS-PTEN and elavGS/UAS-PTEN flies (Fig. 27A). A slight 
difference induced by the RU486 drug was found between the RU486-elavGS/+ and elavGS/+ 
control groups (Fig. 27B). In the second repeat of this experiment, there was still no significant 
change of starvation resistance in RU486-elavGS/UAS-PTEN flies comparing to control flies (Fig. 
27C). The drug-induced difference was not found in the second repeat (Fig. 27D). Turning on 
to the oxidative stress experiment in females, in the first experiment, a significant reduction 
of their resistance to oxidative stress was observed in the RU486-elavGS/UAS-PTEN flies (Fig. 
28A). However, such reduced tolerance was not observed in the experimental flies in the 
second experiment (Fig. 28C). There was no difference caused by the RU486 drug in both 
experiments (Fig. 28B&D). 
In comparison, RU486-elavGS/UAS-PTEN male flies showed a significant increase in starvation 
resistance in both experiments (Fig. 29A&C) and this difference was not caused by the RU486 
drug as there was no difference between the two control groups (Fig. 29B&D). However, the 
resistance to oxidative stress in RU486-elavGS/UAS-PTEN males was not improved in both 
experiments (Fig. 30A&C). RU486-elavGS/+ was significantly short-lived and less resistant to 
oxidative stress in the first experiment (Fig. 30B) but appeared to be normal in the second 
experiment (Fig. 30D).  
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Figure 27. Starvation survival curve of RU486-elavGS/UAS-PTEN and RU486-elavGS/+ (control) 
females. 
A-B: The first starvation experiment on RU486-elavGS/UAS-PTEN females and the control 
groups for drug test (N=100). There was no significant difference between the RU486-
elavGS/UAS-PTEN and elavGS/UAS-PTEN flies but there was a significant difference between 
the RU486-elavGS/+ and elavGS/+ flies (p<0.05 by log-rank test). C-D: The second starvation 
experiment on RU486-elavGS/UAS-PTEN females and the control groups for drug test (N=100). 




Figure 28. Oxidative stress survival curve of RU486-elavGS/UAS-PTEN and RU486-elavGS/+ 
(control) females. 
A-B: The first oxidative stress experiment on RU486-elavGS/UAS-PTEN females and the 
control groups for drug test (N=100). RU486-elavGS/UAS-PTEN flies were significantly less 
resistant to oxidative stress than elavGS/UAS-PTEN flies (p<0.05 by log-rank test). There was 
no difference caused by RU486 drug between the RU486-elavGS/+ and elavGS/+ flies. C-D: 
The second oxidative stress experiment on RU486-elavGS/UAS-PTEN females and the control 
groups for drug test (N=100). There was no significant difference shown in both graphs 





Figure 29. Starvation survival curve of RU486-elavGS/UAS-PTEN and RU486-elavGS/+ (control) 
males. 
A-B: The first starvation experiment on RU486-elavGS/UAS-PTEN males and the control 
groups for drug test (N=100). There was a significant difference between the RU486-
elavGS/UAS-PTEN and elavGS/UAS-PTEN flies (p<0.05 by log-rank test) and there was no 
significant difference between the RU486-elavGS/+ and elavGS/+ flies. C-D: The second 
starvation experiment on RU486-elavGS/UAS-PTEN males and the control groups for drug test 
(N=100). There was a significant difference between the experimental flies (p<0.05 by log-




Figure 30. Oxidative stress survival curve of RU486-elavGS/UAS-PTEN and RU486-elavGS/+ 
(control) males. 
A-B: The first oxidative stress experiment on RU486-elavGS/UAS-PTEN males and the control 
groups for drug test (N=100). There was no significant difference between RU486-
elavGS/UAS-PTEN flies and flies off the drug but there was a significant drug effect on RU486-
elavGS/+ (p<0.05 by log-rank test). C-D: The second oxidative stress experiment on RU486-
elavGS/UAS-PTEN males and the control groups for drug test (N=100). There was no 




6.3 Glycogen and Lipid content assay 
Pan-neural IIS reduction increased lipid content in females; adult-specific neural IIS reduction 
had no effect on energy storage.  
In terms of the glycogen and lipid concentration in elavGAL4/UAS-PTEN flies, the 
concentration of lipid per fly in the elavGAL4/UAS-PTEN females was significantly higher than 
in the two control groups; the level of glycogen in the experimental group was not significantly 
different to both of the controls (Fig. 31A&B). Interestingly, despite the shortened lifespan of 
elavGAL4/UAS-PTEN male flies, there was no significant difference in the glycogen and lipid 
content between those flies and the two control flies (Fig. 31C&D). 
As for the measure of glycogen and lipid content in RU486-elavGS/UAS-PTEN female flies, 
there was no difference in the glycogen concentration between RU486-elavGS/UAS-PTEN and 
elavGS/UAS-PTEN flies but a significant difference was found between RU486-elavGS/+ and 
elavGS/+ flies (Fig. 32A&B). On the other hand, the level of lipid content in RU486-elavGS/UAS-
PTEN did not differentiate from that in elavGS/UAS-PTEN flies and no drug-induced difference 
was detected either (Fig. 32C&D). As for the concentration of glycogen and lipid per fly in 
RU486-elavGS/UAS-PTEN males, there was no difference found between RU486-elavGS/UAS-
PTEN and elavGS/UAS-PTEN flies (Fig. 33A&B) and no difference between the control flies with 




Figure 31. Glycogen and Lipid content of elavGAL4/UAS-PTEN females and males. 
A-B: The average concentration of glycogen and lipid per fly in elavGAL4/UAS-PTEN females 
(N=10). C-D: The average concentration of glycogen and lipid per fly in elavGAL4/UAS-PTEN 
males (N=10). Data are shown as mean value ±SEM. Data were analysed by two-way ANOVA 
followed by post hoc means comparisons using Tukey HSD. * indicates significant differences 





Figure 32. Glycogen and Lipid content of RU486-elavGS/UAS-PTEN and RU486-elavGS/+ 
(control) females. 
A-B: The average concentration of glycogen and lipid per fly in RU486-elavGS/UAS-PTEN and 
RU486-elavGS/+ (control) females (N=20). C-D: The average concentration of glycogen and 
lipid per fly in RU486-elavGAL4/UAS-PTEN and RU486-elavGS/+ (control) females (N=20). Data 
are shown as mean value ±SEM. Data were analysed by two-way ANOVA followed by post hoc 
means comparisons using student’s t test. * indicates significant differences (p<0.05) between 





Figure 33. Glycogen and Lipid content of RU486-elavGS/UAS-PTEN and RU486-elavGS/+ 
(control) males. 
A-B: The average concentration of glycogen and lipid per fly in RU486-elavGS/UAS-PTEN and 
RU486-elavGS/+ (control) males (N=20). C-D: The average concentration of glycogen and lipid 
per fly in RU486-elavGAL4/UAS-PTEN and RU486-elavGS/+ (control) males (N=20). Data are 
shown as mean value ±SEM. Data were analysed by two-way ANOVA followed by post hoc 
means comparisons using student’s t test. * indicates significant differences (p<0.05) between 




6.4 Apoptosis of Drosophila Brain cells 
No difference was found between the Drosophila brains at 30 days old.  
Reducing IIS with the overexpression of PTEN in neurons significantly shortened flies’ lifespan 
and mainly males’ lifespan. It was suspected that the reason for the shortened lifespan was 
due to the detrimental effects caused by PTEN overexpression in the neurons, such as cell 
apoptosis and neurons loss. Therefore, an apoptosis assay was performed on the brain of the 
transgenic Drosophila to observe the differences in the brain structure and the level of 
apoptosing cells between each group. Due to the time limitation of this project, apoptosis 
assay was only performed on RU486-elavGS/UAS-PTEN males at 30 days. The differences in 
the levels of apoptosing cells at this time point between different groups were not significant. 
 
Figure 34. Apoptosis of brain cells in 30-days-old RU486-elavGS/UAS-PTEN and RU486-elavGS/+ 
(control) males. 
A: The average relative area of apoptotic cells per brain in RU486-elavGS/UAS-PTEN and 
elavGS/UAS-PTEN males (N=7). B: The average area of apoptotic cells per brain in RU486-
elavGS/+ and elavGS/+ (N=7). Data are shown as mean value ±SEM. Data were analysed by 














In conclusion, reducing IIS signalling in neurons throughout the lifespan (elavGAL4/UAS-PTEN) 
did not have any effect on flies’ resistance to environmental stress (starvation or oxidative 
stress) in both females and males. Interestingly, reducing IIS signalling only in adult neurons 
(RU486-elavGS/UAS-PTEN) appeared to be able to alter flies’ resistance to environmental 
stress but results varied in different batches. Overall, RU486-elavGS/UAS-PTEN females 
showed no change in starvation resistance and a significant decline in oxidative stress 
resistance in one experiment; RU486-elavGS/UAS-PTEN males were significantly more 
resistant to starvation but normal resistant to oxidative stress. As for the level of glycogen and 
lipid in flies, an increase in the level of lipid concentration was detected in elavGAL4/UAS-PTEN 
females only and there was no other difference observed in either elavGAL4/UAS-PTEN or 
RU486-elavGS/UAS-PTEN flies. For the preliminary apoptosis experiment performed in this 
project, there was no difference in the level of apoptosing cells between different genotypes 





















The lifespan-extending effects of ubiquitous IIS reductions have been well-established in 
different model organisms but there is a lack of understanding of the tissue-specific effects of 
IIS reductions especially in the nervous system. To investigate the neuronal specific effects of 
IIS reductions on health and functional senescence, following the results on elavGAL4/UAS-
InRDN flies (Ismail et al., 2015), this project studied the effects of brain-specific IIS reduction 
using an overexpression PTEN model to reduce IIS signalling. The effects of reduced IIS 
signalling were measured on two different types of locomotor functional senescence, sleep 
patterns senescence, and on survival and fecundity. 
7.1 Constitutive Reduction of IIS Signalling with elavGAL4/UAS-PTEN Transgenic 
Drosophila 
Previously Ismail et al. (2015) investigated the role of neural IIS with elavGAL4/UAS-InRDN flies 
by targeting a mutated insulin receptor (UAS-InRDN) to neurons to reduce IIS signalling. Despite 
the extended lifespan of females, there was no improvement on negative geotaxis and 
neuronal-specific IIS reduction actually had detrimental effects on several parameters of 
exploratory walking at specific age points (Ismail et al., 2015). Their results indicated a 
disconnection between the regulation of lifespan and behavioural senescence by IIS and such 
IIS-induced lifespan extension can occur in the presence of normal, ameliorated, or declined 
behavioural function. Considering the importance of IIS signalling, reducing IIS by targeting the 
insulin receptor may not be the ideal approach and may have detrimental effects on other 
downstream functions. To further investigate the role of IIS in neuronal ageing and function 
and to find the optimal time and space for IIS reduction, this project has chosen a downstream 
factor (the PTEN phosphatase) to reduce IIS.  
PTEN is a lipid and protein phosphatase that dephosphorylates PIP3 to PIP2, removing a critical 
docking site for IIS downstream proteins such as Akt and PDK1, thus, acting as an antagonist 
of PI3K activity and the phosphorylation cascade (Tamguney and Stokoe, 2007). 
Overexpression of dPTEN in the adult fat body was sufficient to increase the lifespan of flies 
by about 20% (Hwangbo et al., 2004). However, overexpression of dPTEN in neurons in this 
study resulted in a normal lifespan and fecundity in females but a significantly shortened 
lifespan in males (Fig. 9). It is suspected that elavGAL4/UAS-PTEN is a stronger knockdown of 
IIS and resulted in long-term detrimental changes in the neurons. The effects of IIS reduction 
are dose-dependent and strong systemic reductions in IIS are known to be detrimental to 
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lifespan due to the pleiotropic nature of the pathway (Ikeya et al., 2009). It is thought that 
there is a different optimal level of IIS reduction for lifespan extension in females and males. 
Sex differences in the study of ageing have long been observed but not fully understood, thus, 
females and males are not directly compared in this project. Severely reducing IIS has 
detrimental effects on flies: mutants, for example, PKB3 homozygotes, InrGC25/InrE19, and Chico 
homozygous males were short-lived and the complete deletion of IIS are lethal in Drosophila 
(Clancy et al., 2001). In addition, PTEN regulates the activity of Akt substrates FOXO, other 
substrates such as the E3 ubiquitin ligase and Bcl2, and the TOR and NOTCH1 signalling to 
control cell proliferation, cell growth, cell differentiation, and apoptosis (Proshkina et al., 
2015). dPTEN mediates both cell number and cell size in flies and regulates the subcellular 
organization of the actin cytoskeleton (Goberdhan et al., 1999). Therefore, the overexpression 
of dPTEN in neurons might cause negative effects on peripheral pathways that outweighed 
the benefits of IIS reduction on ageing and resulted in shortened lifespan in males. However, 
to firmly confirm the knockdown level of IIS in elavGAL4/UAS-PTEN comparing to 
elavGAL4/UAS-InRDN transgenic flies, further experiments are needed such as western blots to 
measure the ratio of phosphorylated Akt vs total amount of Akt in the brains, heads, and 
bodies. On the other hands, it remains unclear the specific mechanism of the effects of 
neuron-specific IIS reduction in the brain and in peripheral tissues that leads to such lifespan 
reduction.      
As a reflection of functional healthspan in long-lived models, negative geotaxis is one of the 
most widely used locomotor behaviour assays, measuring the speed of a fly climbing vertically 
against gravity and its reflex movement ability. It is mostly a measure of neuromuscular 
function that long-lived flies with systemically reduced IIS or muscle-specifically reduced IIS 
both shown improvements on negative geotaxis via improved muscle function (Demontis and 
Perrimon, 2011). Although this locomotor behaviour is controlled by the CNS, long-lived flies 
with neuronal-specific IIS reduction showed no improvement on this behaviour, suggesting 
IIS-mediated improvement on this behaviour is through peripheral tissue rather than neural 
tissue (Ismail et al., 2015). Moreover, a more complicated locomotor behaviour, exploratory 
walking, was proposed as a measure of not only neuromuscular function but also fly’s 
navigation ability and decision-making processes (CNS function) (Martin, 2004). Individual flies 
in small chambers were videoed for 15mins and performance of a range of walking parameters 
(the walking distance, the number of episodes of activity and inactivity, the duration of 
activity, changes in direction, the pattern of exploration, and walking speed) were obtained. 
Most of the parameters present robust age-related changes in normal flies (elavGAL4/+ and 
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UAS-PTEN/+ in Fig. 10): a decrease of walking distance, walking duration, rotation frequency, 
and velocity; and an increase of the duration in the central zone and first rotation time. Ismail 
et al. (2015) also excluded the potential effects caused by the senescence of sensory systems 
(olfaction and vision) on exploratory walking behaviour.  
Unlike elavGAL4/UAS-InRDN flies, reducing IIS pan-neurally throughout the lifespan 
(elavGAL4/UAS-PTEN) showed no effect on locomotor behaviour senescence in both females 
and males (Fig. 10&11). The normal behavioural senescence of negative geotaxis and 
exploratory walking observed in short-lived males support the previous results that lifespan 
and behavioural senescence are independently regulated by IIS signalling in Drosophila. 
Although the elavGAL4/UAS-PTEN females show no significant reductions in locomotor 
behaviours, small non-significant reductions at first age point (10days) of several parameters 
were observed. Such reductions at young age point are in line with elavGAL4/UAS-InRDN flies 
and it is possible that IIS signalling is required for the age-specific neuronal function such as 
during developmental stages. 
Apart from locomotor behaviours, sleep patterns are often used as a measure of functional 
healthspan in long-lived models as well. Sleep in flies shares the fundamental characters of 
sleep with sleep in humans and both show an age-related reduction in sleep quality and 
efficiency (Cirelli, 2009). Ubiquitously reduced IIS in daGAL4/UAS-InRDN or DILP2-3, 5 mutants 
flies has been shown to ameliorate the age-related decline in sleep such that reduced IIS 
increases and consolidates night sleep and decreases day sleep and increases day activity 
(Metaxakis et al., 2014). With the neuron-specific reduction of IIS (elavGAL4/UAS-PTEN flies), 
there were no changes in sleep senescence between the experimental flies and control flies in 
both females and males (Fig. 12-14). In contrast to previous results, a significantly reduced 
daily activity and increased day sleep were observed in elavGAL4/UAS-PTEN females (Fig. 12) 
at the young age. Although not significant at all age points, the experimental flies appeared to 
be less active and sleep longer during the day up to 40 days old but declined to the same level 
of function at older ages comparing to control flies. However, due to the individual variability 
of sleep, such differences between the experimental flies and control flies in females were not 
observed in the second sleeping experiments (Fig. 13). On the other hand, despite shortened 
lifespan, male flies had a normal senescence of sleeping behaviours (Fig. 14). Interestingly, 
there was a lack of age-related decline in the night sleep (total night sleep length and bout 
length in dark) of experimental males (Fig. 14C&G). There was also a small non-significant 
reduction at young age observed in experimental flies in the night sleep but the sleep quality 
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at older ages was not different between the experimental flies and control flies. It is possible 
that the observed lack of age-related decline in elavGAL4/UAS-PTEN males was the result of 
the detrimental effects at the young age rather than ameliorated ageing.   
Taken together, the results from elavGAL4/UAS-PTEN flies so far have supported the earlier 
studies on elavGAL4/UAS-InRDN flies. The IIS pathway modulates lifespan and behavioural 
senescence independently. Significantly short-lived male flies presented a normal senescence 
of locomotor behaviours and daytime sleeping behaviours but showed a negative young age 
effect on nighttime sleep only. The effects of IIS mutation are dose-dependent, and it is 
speculated that PTEN overexpression may result in a stronger knockdown that exceeds the 
optimal level of IIS reduction. When reducing IIS from an embryo, a slightly negative effect on 
behaviours at the young age is often observed and it is thought to be due to the role of IIS in 
development stages. 
7.2 Adult Period Only Reduction of IIS Signalling with elavGS/UAS-PTEN Drosophila 
Constitutive downregulation of IIS could affect the development of the nervous system as well 
as other peripheral tissues and result in the negative effects in behavioural performance 
observed at the young age. To address these possibilities and to investigate the effect of IIS 
reduction in neurons during development and adulthood, lowered IIS was manipulated to 
specifically in the adult nervous system of Drosophila using the inducible GeneSwitch system. 
Work on C. elegans has already indicated that insulin signalling plays different roles during the 
lifecycle that the pathway influences ageing during adulthood only (Dillin et al., 2002). Adult-
only downregulation of IIS was sufficient to increase the lifespan of C. elegans up to 2-fold 
without any detrimental effects to reproduction (Lind et al., 2018). The timing of the effect of 
reduced IIS on lifespan was also studied in Drosophila that overexpression of dFOXO in the 
adult fat body increased female lifespan by 20 to 50% but had negative effects on fecundity 
(Giannakou et al., 2004).  
When reducing IIS in adult neurons, the lifespan of RU486-elavGS/UAS-PTEN females was 
shortened in one experiment (Fig. 15A) but normal in a larger population experiment (Fig. 
16A). As flies are from different batches in the two experiments, such difference in lifespan 
may be the result of variability in the health of parental strain or environmental factors (such 
as food quality, bacteria, or drug interventions) (Linford et al., 2013). A drug-induced lifespan 
difference was observed in the second lifespan results (Fig. 16C). Furthermore, RU486-
elavGS/UAS-PTEN females presented a consistent reduction in fecundity (Fig. 15B & Fig. 16B) 
106 
 
but this is most likely a result of RU486 itself and not a result of reduced IIS in neurons (Fig. 
15D & Fig. 16D). The inducer for the GeneSwitch system, RU486 (mifepristone), is a 
progesterone receptor antagonist and glucocorticoid receptor antagonist used for birth 
control and abortion (Landis et al., 2015). The effects on fertility in GeneSwitch transgenic flies 
are subject to the concentration of RU486 (Osterwalder et al., 2001; Copeland et al., 2009). 
Therefore, further adjustments on the concentration of RU486 should be made to induce gene 
alterations without negative effects. On the other hand, RU486-elavGS/UAS-PTEN males were 
significantly short-lived (Fig. 17A&B), confirming that adult-restricted IIS manipulation in 
neurons was sufficient to influence lifespan and suggesting that the UAS-PTEN driver may 
result in a stronger downregulation of IIS. In addition, PTEN is a central regulator that plays an 
essential role in the control of cell growth, cell division, cell number, and organ size and 
apoptosis (Gao et al., 2000). The overexpression of PTEN can lead to the reduction of cell 
number, cell size, and the induction of cell apoptosis (Song et al., 2007). Therefore, apart from 
the downregulation of IIS, the shortened lifespan of UAS-PTEN transgenic flies may also be the 
results of disrupted PTEN functions in other aspects. 
To further investigate whether the detrimental effects on exploratory walking in 
elavGAL4/UAS-InRDN flies is the effects on neuronal ageing or neuronal function, in addition to 
the normal behavioural testing, a recovery behavioural experiment was designed by 
controlling the inducible drug to adjust the timing and level of IIS signalling. In parallel to 
normal behavioural testing, a 5-day recovery period was given to flies to allow a recovery of 
insulin function before testing. This experiment was to observe if an improvement in 
behavioural senescence following a recovery of IIS function was presented.  
In RU486-elavGS/UAS-PTEN females, the experimental flies also showed a normal 
performance of the locomotor behaviours at young ages but their performance deteriorated 
faster at older ages and significantly at age 40 days (Fig. 18A-H). An overall faster decline 
appeared in RU486-elavGS/UAS-PTEN males and the differences were significant at older ages 
(age 40 or 50 days) (Fig. 20A-H). The detrimental effects of adult-specific PTEN overexpression 
in neurons on behavioural function support earlier studies on elavGAL4/UAS-InRDN, showing 
that reduced IIS in neurons is not beneficial to behavioural function (Ismail et al., 2015). By 
giving a 5-day recovery period, both females and males showed either a normal behavioural 
senescence or an improved senescence compared to flies without a recovery period (Fig. 18I-
P & Fig. 20I-P). These data suggest that a 5-day recovery was sufficient to restore IIS function 
and bring behavioural performance back to the normal range for most parameters but was 
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not sufficient for some parameters. Moreover, the recovery period only restored their normal 
behavioural functions but did not improve any behavioural senescence following recovery. 
Such rehabilitation from the detrimental effects but lack of improvement in locomotor 
behavioural senescence following recovery from PTEN overexpression may indicate that 
reduced IIS is detrimental to neuronal function and does not influence neuronal ageing. It is 
possible that if IIS function is required for the normal performance of locomotor behaviours, 
the requirement of IIS function to maintain normal behaviours may be increasing with age as 
the differences between RU486-elavGS/UAS-PTEN and elavGS/UAS-PTEN flies became 
significant with age. It is also possible that over-expression of PTEN resulted in either long-
lasting detrimental effects on neurons via its modulation of other pathways. We attempted to 
determine if levels of apoptosis in the brain were altered by PTEN expression but due to time 
restraints, only males at age 30 days were analysed, with no significant differences observed. 
Further analysis of apoptosis and other downstream effects of PTEN expression should be 
made on male and female flies at multiple ages throughout the lifespan.  
Over the past few decades, researches have established that plasticity mechanisms such as 
long-term potentiation (LTP) and synapse formation are altered at older ages, contributing to 
the decline in cognitive function during normal ageing (Barnes, 2011). The disruption of normal 
synapse formation of ageing neurons is thought to alter connectivity and higher-order 
integration and in fact, significant changes in the expression of synaptic genes have been found 
across ageing mouse, monkey, and human brains (Bishop et al., 2010). In Drosophila, PI3K 
regulates the number of synapses in both larval motor neurons and adult brain projection 
neurons that PI3K activation is required for inducing synaptogenesis in aged adult neurons and 
synapse maintenance (Martin-Pena et al., 2006). It is possible that IIS mediates effects on 
neuronal ageing and function via PI3K and the requirement of IIS/PI3K function increases with 
age in the maintenance of cognitive function. Additionally, brain-specific ageing analysis has 
revealed conserved mechanisms of progressive mitochondrial dysfunction and oxidative 
damage that IIS may mediate effects on age-specific function and behaviour via the regulation 
of such as protein clearance, oxidative stress, DNA repair, and apoptosis (Bishop et al., 2010). 
Given the beneficial effect of reduced IIS on lifespan and peripheral cell ageing, it is plausible 
to assume that the detrimental functional effects on walking behaviour and negative geotaxis 
caused by the overexpression of PTEN outweigh any positive effects of IIS reduction on 
neuronal ageing. It is possible that reduced neuronal IIS by PTEN overexpression results in 
long-term detrimental changes in the brain, such as apoptosis or neuron loss that could be 
induced by PTEN overexpression, that the fly cannot recover from, as mentioned above. It has 
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also been suggested that different types of cognitive and behavioural functions have different 
levels of sensitivity to IIS changes with age (Ismail et al., 2015). Thus, some parameters of the 
behaviour are more sensitive to changes in IIS with age and shown significant decline while 
other parameters show no differences overall. Because of the variable sensitivity, the 5-day 
recovery period may not be sufficient for some parameters and the differences persist. 
Interestingly, there is a small significant improvement on negative geotaxis of RU486-
elavGS/UAS-PTEN recovery males at old age (Fig. 20P) which is similar to the long-lived 
daGAL4/UAS-InRDN and Chico mutant (Ikeya et al., 2006; Martin and Grotewiel, 2006). It is 
more likely to be that the recovery of IIS function counterpoised the detrimental effects of 
strong IIS reduction and revealed the positive effects of mild IIS reduction. The improvement 
may be a positive functional effect as the overall senescence of the two locomotor behaviours 
was not improved. Overall, based on these results and previous studies, it is clear that reduced 
IIS is detrimental to behavioural function. However, to make firm conclusions about the role 
of IIS in neuronal ageing, the effect of reduced IIS on factors such as cell death throughout the 
lifespan, needs to be determined. 
One of the difficulties of using inducible system GeneSwitch is to rule out the effects of RU486 
on Drosophila’s behavioural performances. RU486-elavGS/+ and elavGS/+ groups were tested 
as control groups for drug effects. There were slight differences between the exploratory 
walking of the two control groups (Fig. 19&21), however, they did not explain the differences 
between the elavGS/UAS-PTEN +/-RU486 groups, suggesting that the effects seen in RU486-
elavGS/UAS-PTEN +RU486 were IIS-induced detrimental effects rather than RU486-induced 
effects. On the other hand, RU486-elavGS/UAS-PTEN appeared to be hyperactive and sleep 
less during the day (Fig. 22&24) and similar patterns were found between RU486-elavGS/+ 
and elavGS/+ groups (Fig. 23&25), suggesting such differences are drug-induced differences 
rather than lowered IIS-induced differences. However, other differences observed in the 
experimental groups cannot be explained by drug effects. 
When reducing IIS in adult neurons via PTEN expression, significantly detrimental effects were 
presented at the first time point in both females and males (Fig. 22&24). Such young age 
effects are similar to the small non-significant negative effects found in elavGAL4/UAS-PTEN, 
suggesting that the early age effects were not due to developmental deficiency from embryos. 
In addition, a lack of age-related decline was seen in the daytime sleep pattern of RU486-
elavGS/UAS-PTEN males (Fig. 24E-H), leading to some significant differences between the two 
groups at older ages. By giving a 5-day recovery period, experimental flies appeared to recover 
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from the early age detrimental effects and the significant differences no longer persisted (Fig. 
22&24). Moreover, a restoration of the age-related changes was also seen in the sleep 
patterns of male flies (Fig. 24M-P) and the significant differences at older ages were recovered. 
A complete or partial recovery from the detrimental effects of PTEN expression was found in 
all parameters in RU486-elavGS/UAS-PTEN recovery flies, but there was no improved 
behavioural senescence. Therefore, in contrast to the speculations in Metaxakis et al. (2014), 
the results presented here showing no age-related deterioration in flies with reduced IIS do 
not indicate an amelioration of sleep senescence and may indicate detrimental functional 
effects at the young age that flies cannot recover from. A 5-day recovery period was sufficient 
to restore some of the IIS function and their normal behavioural performances, but future 
studies could investigate different time scales of recovery as well as different doses of RU486 
to alter the level of PTEN expression. 
Like in mammals, sleep patterns in Drosophila are thought to be regulated by the coordination 
of many different neurons and interconnected brain circuits (Tomita et al., 2017). In the 
Drosophila brain, the mushroom bodies (MBs) are a paired neuropil structure in the central 
brain, including the dendritic calyx, peduncle, and lobes, and are critical for associative 
learning and memory (Akalal et al., 2006). MBs also regulate sleep such that the ablation of 
the MBs reduces sleep and the inhibition of the MBs function via electrical silencing and 
increasing excitation also alter sleep (Joiner et al., 2006). MBs regulate sleep bi-directionally 
through MB output neurons (MBONs): the cholinergic MBONs promotes sleep and multiple 
glutamatergic MBONs promotes wakefulness (Aso et al., 2014). Many neurotransmitters such 
as dopamine, GABA, or serotonin can regulate sleep through the MBs (Tomita et al., 2017). On 
the other hand, the central complex (CC) is the central neuropil structures in the Drosophila 
brain and the higher centre regulating locomotor behaviours, consisting of the protocerebral 
bridge (PB), the fan-shaped body (FB), the ellipsoid body (EB), and the noduli (NO) (Strauss, 
2002). Over the years, the involvement of CC in sleep regulation has been reported and the 
D1-like dopamine receptor expressed in the EB neurons regulates startle-induced and 
nocturnal arousal and dopaminergic neurons also project to the dorsal FB and promote sleep 
(Lebestky et al., 2009; Ueno et al., 2002). Sleep-wake cycles are also tightly regulated by the 
circadian clock and the circadian clock pacemaker neurons in Drosophila, LNds and LNvs, 
regulate nighttime and daytime sleep separately (Cong et al., 2015).  
It is clear that the sleep-wake cycle is regulated by different regions of Drosophila brain 
separately but also interactively. The alteration of sleep behaviour could be the results of 
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global changes in the brain or changes to specific loci that signal to the rest of the brain. 
Therefore, it is thought that different parameters of sleep behaviour may be differentially 
sensitive to IIS reductions. Thus, some parameters do not show significant changes when 
reducing IIS while some may be too sensitive to IIS reductions that the detrimental effects 
could not be completely recovered. Despite no differences in the sleep patterns with age 
overall, interestingly, there are several cases where the RU486-elavGS/UAS-PTEN recovery 
flies appeared to be worse than RU486-elavGS/UAS-PTEN flies at the first or the last time 
points. As observed in the figures, this may also due to the variable performance of the 
baseline, the elavGS/UAS-PTEN flies, which are from different batches. Therefore, further 
adjustments of the experiments are needed where all three groups (RU486-elavGS/UAS-PTEN, 
elavGS/UAS-PTEN, RU486-elavGS/UAS-PTEN recovery) should be from the same batch for 
genetic and environmental control and the experiments should be performed on them at the 
same time to confirm the differences between each group. In addition, in consideration of the 
variability in the rates and onsets of different functional declines (Grotewiel et al., 2005), it is 
also suspected that the likely differential sensitivity to IIS manipulation is related to different 
CNS cell types. The effects on behavioural and functional senescence with pan-neural IIS 
reduction may be the combination of positive, negative, and neutral effects of IIS reduction 
on individual neuronal types or circuits in the brain (Ismail et al., 2015). Therefore, future 
studies are needed to determine the role of each neuronal subtype or structure in the brain 
in modulating lifespan and behavioural senescence, and to study the changes in the 
downstream signalling mechanisms in specific tissues in response to IIS reduction. 
Taken together, reducing IIS via PTEN expression during the adult period only significantly 
shortens male lifespan and has detrimental effects on behavioural senescence for both 
females and males. These results have supported earlier studies on elavGAL4/InRDN that 
reduced IIS in neurons is not beneficial to the neural circuitry function underlying behavioural 
senescence. In this study, the lack of improvement in behavioural senescence following a 
recovery of IIS function suggests reduced IIS is detrimental to neuronal function and does not 
ameliorate neuronal ageing. The lack of age-related changes in some parameters observed in 
this study and previous studies may be the result of long-term detrimental changes from the 
young age that fly cannot recover from rather than delayed ageing. However, further 
experiments testing the exact detrimental changes in neurons are needed for making firm 
conclusions about the role of IIS in neuronal ageing. It has also appeared that fly’s behavioural 
senescence when reducing IIS during adulthood (RU486-elavGS/UAS-PTEN) was worse than 
reducing IIS from the embryo (elavGAL4/UAS-PTEN). It is suspected that elavGS driver is 
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stronger expression driver than elavGAL4, rather than due to the different roles of IIS in 
adulthood and development. This will also need further determination using western blots 
before making firm conclusions. 
7.3 Stress Resistance, Energy Storage, and molecular analysis of transgenic Drosophila 
Reducing IIS in specific tissues such as fat bodies, muscles, or brain is sufficient to alter lifespan, 
but it still remains unclear the mechanisms of how reducing IIS in specific tissues affects the 
rest of the body. It is thought that reducing IIS in the neurons may affect insulin signalling 
elsewhere in the body leading to the shortened lifespan of flies. Apart from longer lifespan, IIS 
reduction in the model organism is often accompanied with altered metabolism and increased 
stress resistance (Piper and Partridge, 2018). It is known that genetic manipulations of 
nutrient-sensing pathways can also mediate responses to environmental stressors such as 
starvation, oxidative stress, and thermal stress through the similar mechanisms of lifespan 
modulation (Sepil et al., 2016). Long-lived model C. elegans presented increased resistance to 
thermal and oxidative stress and long-lived D. melanogaster appeared increased resistance to 
oxidative stress and starvation but reduced resistance to thermal stress (Zhou et al., 2011; 
Broughton et al., 2005).  
Surprisingly, constitutively reducing IIS in neurons (elavGAL4/UAS-PTEN) did not improve or 
reduce resistance to starvation and oxidative stress, despite the shortened lifespan of males 
(Fig. 26). In RU486-elavGS/UAS-PTEN flies with IIS reduction in adult neurons, females 
exhibited no changes in starvation resistance but reduced tolerance to oxidative stress in one 
experiment (Fig. 27&28). On the other hand, males appeared to be more resistance to 
starvation but showed the same level of tolerance to oxidative stress (Fig. 29&30). On the 
other hand, an increase in the level of lipid was found in elavGAL4/UAS-PTEN females (Fig. 
31B) but neuron-restricted IIS reduction throughout lifespan or during adulthood period only 
did not alter the level of lipid and glycogen in other cases (Fig. 31-33). It is known that IIS 
signalling pathway is a complex pathway that controls stress responses and metabolism and 
the regulation of protein and glycose metabolism is thought through different DILPs. DILP2 
regulates the level of blood sugar, DILP5 regulates protein metabolism, while DILP3 is thought 
to mediate lipid metabolism (Grönke et al., 2010; Broughton et al., 2010; Varghese et al., 
2010). It is possible that neuron-restricted IIS reduction was not sufficient to alter the stress 
resistance or glycogen and lipid metabolism in the whole body and altered metabolism caused 
by IIS reduction is due to changes in the peripheral tissues rather than in the CNS. It is also 
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thought that the modulation of stress resistance and energy storage by the IIS pathway is an 
independent mechanism from the lifespan modulation. 
However, it remains unclear the exact mechanisms of the early death of flies led by IIS 
reduction in neurons until further investigations. Further molecular analysis of the expression 
of downstream factors of the IIS pathway will bring to light the effects of neuronal IIS reduction 
in the CNS and in the peripheral tissues. One of the molecular analysis is the apoptosis assay 
to observe the neuron deaths in different genotypes. However, there was no significant effect 
on the levels of apoptosing cells between each group at age 30 days (Fig. 34). It is suspected 
that the major differences between each group were found at older ages and thus, the 
differences in the brain damage were not clear yet at 30 days old. This analysis needs to be 
performed at different age points throughout lifespan especially at older age points and also 
performed with larger numbers of fly brains. In addition, QPCR and western blot could be used 
to measure the gene expression level of insulin-like peptides (DILPs) in heads and bodies and 
the level of DILP proteins in insulin-producing cells, to understand the effects on the 
expression, production, and release of DILPs. Immunohistochemistry assay could be used to 
examine the level of Akt phosphorylation and FOXO localisation in the neurons.  
In conclusion, so far, the results from this project has confirmed that IIS modulates lifespan 
and behaviour independently and normal behaviour senescence can occur in the presence of 
shortened lifespan. In comparison to the studies on elavGAL4/UAS-InRDN flies, it is thought 
that there is an optimal level of reduction of IIS for lifespan extension which is different for 
females and males, the PTEN transgene results in a stronger knockdown of IIS in neurons 
compared to the InRDN transgene. Strongly reducing IIS during the adult period only shortens 
lifespan and has detrimental effects on behavioural senescence. However, such detrimental 
effects can be recovered when given a recovery period of IIS function, suggesting the theory 
that the effect of reduced IIS in neurons on behavioural senescence is the result of changes to 
neuronal function rather than neuronal ageing. Reduced IIS in neurons plays a role in the 
regulation of sleep and activity but does not alter normal age-related changes. Reduced IIS in 
neurons can also alter some stress responses but not metabolism level, still, further molecular 
analysis will be needed to investigate the exact mechanisms of the effects of neuron-specific 
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